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1. Summary 
  
Based on chemical and enzyme catalyzed procedures, new carbohydrate derived 
azides were synthesized. These azides are expected to have a wide range of 
pharmaceutical and technical applications. Starting from cellobiose, a chemical 
synthetic pathway has been developed, based on a conventional protection-
deprotection scheme to synthesize 6'-azido-6'-deoxy-cellobiose (in which the azido 
group is located on the non-reducing glucose unit).  In a similar way 6-azido-6-deoxy-
cellobiose was also synthesized. Both cellobiose derivatives can act as precursors 
for enzyme-catalyzed syntheses of new aminopolysaccharides or chemical 
polymerization into biomimetic polymers. The two azido derivatives of cellobiose 
were enzymatically oxidized under catalysis by the cellobiose dehydrogenase to the 
corresponding lactones. These lactones can function as monomers for the synthesis 
of new hydrogels.  6-Azido-6-deoxy-D-glucose was also obtained from glucose by a 
conventional protocol in 10 steps. This azido sugar can be used as a monomer in the 
synthesis of 6-amino-6-deoxycellulose. Furthermore we have shown that 6-azido-6-
deoxy-cellobiose can also be formed by reversal phosphorylase reaction, starting 
from glucose 1-phosphate and 6-azido-6-deoxy-D-glucose. While the forward 
phosphorylase reaction using 6-azido-6-deoxy-cellobiose as starting material and 
inorganic phosphate as buffer resulted in 6-azido-6-deoxy-D-glucose as expected. 
That means the azido group on C-6 of glucose as well as of cellobiose is tolerated by 
the enzyme cellobiose phosphorylase. In our hands 6'-azido-6'-deoxy-cellobiose did 
not function as a substrate for cellobiose phosphorylase. Further investigation may 
be required to confirm our observation.  In alternative pathway we have synthesized 
3-azido-3-deoxy-D-glucose as well as β-D-allose starting from 1,2:5,6-di-O-
isopropylidene-α-D-glucofuranose. Our purpose of getting these key intermediates 
was on one hand to be used as precursors in oligosaccharides synthesis, on the 
other hand to test them as substrates for the reversal cellobiose phosphorylase 
reaction. In the enzyme-catalyzed synthesis we have used the enzyme cellobiose 
phosphorylase extracted from Clostridium thermocellum. In the reverse reaction, 
CBP catalyzes the production of heterodisaccharides from various derivatives of 
glucose. For this purpose we have used β-D-allose, 6-azido-6-deoxy-D-glucose and 
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3-azido-3-deoxy-D-glucose as different substrates for the action of CBP. The only 
heterodisaccharide formed was that from 6-azido-6-deoxy-D- glucose, which means 
substitution of hydroxyl group by azido group in the six position of glucose seems to 
be tolerated by cellobiose phosphorylase, whereas the 3-azido analogue did not 
react. This observation showed that the role of the hydroxyl group or its azide 
derivative at C-6 is less critical than that of the hydroxyl at C-3. The absence of 
heterodisaccharide in case of β-D-allose showed that the equatorial configuration on 
C-3 is necessary for the binding on the active site of the enzyme. 
 
Another useful application of 6-azido-6-deoxy-D-glucose remains in its ability to be 
coupled in 1,3-dipolar cycloaddition reaction to an alkyne. We have coupled 6-azido-
6-deoxy-D-glucose to ethylpropiolate to get a stable triazole. This triazole can be 
used as a part of a diagnostic system for testing of anti-carbohydrate IgE antibodies. 
In which the alkyne-azide coupled system act as a linking arm between the 
glycopeptide of interest and a micro titre plate to which the other end of triazole is 
immobilised. 
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Zusammenfassung 
 
Basierend auf chemischen- und Enzym-katalysierten Verfahren wurden neue 
Azidozucker synthetisiert. Ausgehend von Cellobiose ist ein synthetisch- chemischer 
Weg auf der Grundlage eines konventionellen Schemas entwickelt worden, um eine 
6'-Azido-6'-deoxy-cellobiose (in welcher sich die Azido-Gruppe an der nicht 
reduzierenden Glukose-Einheit befindet) zu synthetisieren. Auf ähnlichem Wege 
wurde auch 6-Azido-6-deoxy-cellobiose synthetisiert. Beide Cellobiose-Derivate 
können als Vorläufer für Enzym-katalysierte Synthesen von neuen 
Aminopolysacchariden oder für die chemische Polymerisation in biomimetische 
Polymere fungieren. Die beiden Azido-Derivate der Cellobiose wurden unter Katalyse 
durch Cellobiose Dehydrogenase in die korrespondierenden Lactone enzymatisch 
oxidiert. Diese Lactone können als Monomere für die Synthese neuer Hydrogele 
fungieren. 6-Azido-6-deoxy-D-glucose wurde ebenso in einem konventionellen 10-
Schritte-Protokoll erhalten. Dieser Azido-Zucker kann als Monomer bei der Synthese 
von 6-Amino-6-Deoxycellulose verwendet werden. Darüber hinaus haben wir 
gezeigt, dass die 6-Azido-6-deoxy-cellobiose auch durch die Rückreaktion der 
Phosphorylase ausgehend von Glucose 1-Phosphat und der 6-Azido-6-deoxy-D-
glucose erzeugt werden kann, während die Hinreaktion der Phosphorylase unter 
Benützung 6-Azido-6-deoxy-cellobiose als Substrate und des anorganischen 
Phosphats als Buffer wie erwartet in einer 6-Azido-6-deoxy-D-glucose resultierte. 
Dies bedeutet, dass die Azido-Gruppe in der C-6 der Glucose als auch der 
Cellobiose durch die Cellobiose Phosphorylase toleriert wird. Bei unseren 
Untersuchungen erwies sich 6'-Azido-6'-deoxy-cellobiose nicht als Substrat für die 
Spaltung durch Cellobiose Phosphorylase. Auf alternativem Wege haben wir sowohl 
3-Azido-3-deoxy-D-glucose als auch β-D-Allose ausgehend von 1,2:5,6-Di-O-
isopropyliden-α-D-glucofuranose synthetisiert. Unser Ziel bei der Herstellung dieser 
Schlüsselsubstanzen war einerseits sie als Vorläufer in der Oligosaccharid Synthese 
zu verwenden und andererseits sie als Substrate bei der Rückreaktion der Cellobiose 
Phosphorylase zu testen. Bei der Enzym-katalysierten Synthese haben wir die aus  
Clostridium thermocellum extrahierte Cellobiose Phosphorylase(CBP) verwendet. Bei 
der Rückreaktion katalysiert die CBP die Produktion von Heterodisacchariden aus 
verschiedenen Glucose-Derivaten. Für diesen Zweck haben wir β-D-Allose, 6-Azido-
6-deoxy-D-glucose und 3-Azido-3-deoxy-D-glucose als unterschiedliche Substrate 
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für die CBP verwendet. Das einzige gebildete Heterodisaccharid entstand aus der 6-
Azido-6-deoxy-D-glucose. Das bedeutet, dass die Substitution der Hydroxyl-Gruppe 
durch die Azido-Gruppe in der sechsten Position der Glucose von der Cellobiose 
Phosphorylase toleriert wird, während das 3-Azido-Analoge nicht reagierte. Dieses 
Ergebnis zeigt, dass die Rolle der Hydroxyl-Gruppe oder des Azids am C-6 weniger 
kritisch ist als das Hydroxyl am C-3. Das Fehlen von Heterodisacchariden im Falle 
der β-D-Allose zeigt, dass die äquatoriale Konfiguration am C-3 für die Bindung am 
aktiven Zentrum des Enzyms erforderlich ist. 
Eine andere nützliche Anwendung der 6-Azido-6-deoxy-D-glucose liegt in ihrer 
Fähigkeit in einer 1,3-dipolaren Cycloadditionsreaktion mit einem Alkin gekoppelt zu 
werden. Wir erhielten ein stabiles Triazol durch die Kopplung von 6-Azido-6-deoxy-D-
glucose mit Ethylpropiolat. Dieses Triazol kann als Teil eines diagnostischen 
Systems zur Bestimmung von Anti-Carbohydrat-IgE-Antikörpern verwendet werden, 
wobei das Alkin-Azid-Kopplungssystem als Bindungsarm zwischen dem zu 
untersuchenden Glycopeptid und der Mikrotiter-Platte fungiert, an der das andere 
Ende des Triazols immobilisiert wird. 
Es wird erwartet, dass die im Rahmen der vorliegenden Arbeit synthetisierten 
Azidozucker einen vielfältigen pharmazeutisch-technischen Anwendungsbereich 
finden werden. 
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2.  Introduction 
 
 Carbohydrate derived azides are important synthetic intermediates. In this 
work new approaches have been explored to design new azido sugars with 
unique structures for pharmaceutical and technical applications. These 
applications include the synthesis of new aminopolysaccharides as 
pharmaceutical excipients, hydrogels and new stable carbohydrate derived 
1,2,3-triazoles for diagnostic purposes. 
 
2.1  Pharmaceutical applications of β-glycans  
 
 
2.1.1 Cellulose and its derivatives 
 
 
Cellulose is the most abundant biopolymer on earth, the molecular and 
supramolecular structure of this macromolecule allows a lot of important applications. 
The cellulose formed by plants is the main source of this biopolymer but it is 
accompanied by many copolymers of biogenic origin, e.g. lignins, hemicelluloses, 
proteins. These impurities make the production of pure cellulose costly. 
 
 
 
 
 
 
Cellulose is a polydisperse, linear homopolymer consisting of regio- and 
enantioselective  β-1,4-glycosidic linked D-glucose units. It contains three reactive 
Figure 1.  Cellulose 
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hydroxyl groups at the C-2, C-3, and C-6 positions, which are, in general, accessible 
to typical conversions of primary and secondary alcoholic groups. Hydrogen bonding 
between these hydroxyl groups leads to various supramolecular, semicrystalline 
cellulose structures; thus, crystallinity and H-bonding associations have a strong 
influence on its ultimate chemical reactivity and solubility characteristics. As a 
consequence of its inherent polyfunctional structure, naked cellulose is insoluble in 
water as well as common organic solvents. New cellulose derivatives with 
supramolecular architectures are of increasing interest due to their various 
applications, such as in ultra-thin coatings, host-guest systems, biosensors, liquid 
crystalline polymers, and biomaterials. Regioselective functionalization of cellulose, 
i.e. the introduction of either a substituent or more than one substituent onto the 
cellulose chain at specific hydroxyl group, has attracted ever-increasing attention 
because of its potential to prepare precisely modified cellulose materials possessing 
new properties differing from those derived from simple statistical substitution1. The 
distribution of substituents in cellulose derivatives is considered to be one of the most 
influential factors determining their physical properties, such as, solubility, 
crystallization, gel formation, liquid crystal formation, and also resistance to enzymic 
degradation2.    
 
 
MICROCRYSTALLINE CELLULOSE (Avicel®) 
 
Avicel®  is manufactured by the controlled hydrolysis of α-cellulose, obtained as a 
pulp from fibrous plant materials, with dilute mineral acid solutions. 
Following hydrolysis, the hydrocellulose is purified by filtration and the aqueos slurry 
is spray dried to form dry, porous particles of a broad size distribution ( Table1). 
 
Function,  
Tablet and Capsule diluent; tablet disintegrant; suspending and/or viscosity 
increasing agent. 
 
Molecular wt. and Formula , (36,000 approx.) (C6H10O5)n  n = 220. 
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White, odourless, tasteless, crystalline powder composed of porous particles. 
 Available in different size grades with different properties i.e 101 and 102 
 
 
 
Type Particle size in µm 
PH- 101 50 
PH- 102 100 
PH- 103 50 
PH- 104 20 
Table1 
 
 
Application in pharmaceutical formulation or technology use; 
 
 
use concentration % 
Tablet binder / diluent ( wet granulation) 5-20 
Tablet binder / diluent ( direct compression) 5-20 
Tablet disintegrant 5-15 
Tablet glidant 5-15 
Anti-adherent  5-20 
Adsorbent -- 
Capsule diluent 10-30 
 
POWDERED CELLULOSE (Elcema®) 
 
Is naturally occurring cellulose and is manufactured by mechanical processing of α-
cellulose obtained as a pulp from fibrous plant materials, and is commercially 
available in different types as shown in Table 2. Powdered cellulose occurs as a 
 
Figure 2 Microcrystalline cellulose 
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white, odourless, tasteless, powder of various finenesses, ranging from a free-
flowing, dense powder to a coarse, fluffy, non-flowing material. 
 
Function, Tablet and Capsule diluent; sorbent and suspending agent. 
Molecular wt. and Formula, (243,000 approx.) (C6H10O5)n    n = 1500 
 
Type 
 
Particle size in µm 
Elcema Grade 
P050 
 
1-50 
P 100 1-100 
P 150 1-150 
P 250 1-250 
 
Application in pharmaceutical formulation or technology use; 
 
use concentration % 
Binder 5-20 
Filler -- 
Disintegrant 5-15 
 
 
HYDROXYETHYL CELLULOSE 
 
A purified form of cellulose is reacted with sodium hydroxide to produce a swollen 
alkali cellulose. This alkali-treated cellulose is chemically more reactive than 
untreated cellulose. By reacting the alkali cellulose with ethylene oxide, a series of 
hydroxyethyl cellulose ethers is produced.  
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Function, 
Suspending and/ or viscosity-increasing agent 
Others: Binder; film-former; thickener 
 
Applications in pharmaceutical formulation or technology use; 
 
Hydroxyethyl cellulose is an effective film former, binder, thickener, stabilizer and 
dispersant in shampoos, hair sprays, neutralizers, creams and lotions.  
 
HYDROXYPROPYLCELLULOSE  
 
Hydroxypropylcellulose is manufactured by reacting alkali cellulose with propylene 
oxide at elevated temperatures and pressures. The propylene oxide can be 
substituted on the cellulose through an ether linkage at the three reactive hydroxyls 
present on each anhydroglucose monomer unit of cellulose chain.  
 
Function,  
Suspending and/or viscosity-increasing agent; coating agent 
Others: Emulsifier; film former; protective colloid; stabilizer; suspending agent; 
thickener; binder; and granulating agent.  
 
Molecular wt. and Formula, (50,000 – 1,250,000)    (C15H28O8)n  
   
 
 
 
 
 
 
 
  
Figure 3   hydroxypropylcellulose 
 
15 
 
Applications in pharmaceutical formulation or technology use; 
 
Granulating agent (binder), Film coating, thickener, microencapsulation. 
These properties depend on the molecular weight.   
 
 
Hydroxypropyl Methylcellulose  
 
Method of Manufacture; 
  
  Cellulose fibers, obtained from cotton linters or wood pulp, are treated 
with sodium hydroxide solution. The alkali cellulose thus obtained is in turn treated 
with methyl chloride and propylene oxide to produce methylhydroxypropyl ethers of 
cellulose. The fibrous reaction product is then purified and ground to a fine, uniform 
powder or granules. 
 
Function,  
Suspending and/or viscosity-increasing agent;  
tablet binder; coating agent; film former 
 and emulsion stabilizer. 
 
Molecular wt. and Formula;  
Approx. 86,000 C8H15O6 – (C10H18O6)n – C8H15O5 
 
Application in pharmaceutical formulation or technology use 
 
Film-former in tablet film coating, binder in tablet granulations, thickening agent 
added to vehicles for eye drops and artificial tear solutions, emulsifier, suspending 
agent and stabilizer in gels and ointments. 
 
Figure 4 
Hydroxypropylmethylcellulose 
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2.2 Chitosan 
 
Chitosan has been considered for pharmaceutical formulation and drug 
delivery applications in which attention has been focused on its absorption-
enhancing, controlled-release and bioadhesive properties. Synthesized from a 
naturally occurring source, this polymer has been shown to be both biocompatible 
and biodegradable. Chitosan is a linear copolymer of β(1-4) linked 2-acetamido-2-
deoxy-β-D-glucopyranose and 2-amino-2-deoxy-β-D-glucopyranose. 
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It is easily obtained by deacetylation of chitin (Fig.5), a polysaccharide widely 
distributed in nature (e.g. shells of crustaceans, insects and certain fungi). The 
degree of deacetylation affects the solubility of chitosan in aqueous solutions, the 
polymer is soluble in acidic solutions and slightly soluble in weakly alkaline solutions.  
 
Chitosan lacks irritant or allergic effects and is biocompatible with both healthy and 
infected human skin. The intriguing properties of chitosan have been known for many 
years and the polymer has been used in the field of agriculture, industry and 
medicine. In agriculture, chitosan has been described as a plant antivirus, an additive 
in liquid multicomponent fertilizers and it has also been investigated as a metal-
recovering agent in agriculture and industry. Chitosan has been noted for its 
Figure 5  Chitosan 
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application as a film-forming agent in cosmetics, a dye-binder for textiles, a 
strengthening additive in paper and a hypolipidic material in diets. It has been used 
extensively as a biomaterial, owing to its immunostimulatory activities, anticoagulant 
properties , antibacterial and antifungal action and for its action as a promoter of 
wound healing in the field of surgery. 
 In addition chitosan has a variety of promising pharmaceutical uses and is 
presently considered as a novel carrier material in drug delivery systems.  
 
 
Pharmaceutical Applications Of Chitosan 
 
 
Oral drug delivery 
 
The bioavailability of drugs has been improved by the use of 
mucoadhesive dosage forms. By prolonging the residence time of drug 
carriers at the absorption site, sustained release and improved 
bioavailability of drugs can be achieved. 
Chitosan has better mucoadhesive properties compared with 
hydroxypropylcellulose and carboxymethylcellulose 3. Among chitosans 
of various ranges of molecular-weight, better mucoadhesion was 
 
 
 
 
Figure 6  Scanning electron micrographs (SEM) from porous chitosan 
scaffolds. Nettles, D.L.; Evaluation of chitosan as cell scaffolding material 
for cartilage tissue engineering; Mississippi State University, 2001 
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observed for higher-molecular weight (approximately 1400 kDa) 
compared to lower-molecular weight chitosans ( 500 to 800 kDa).    
 
Parenteral drug delivery 
 
In controlled-release technology, biodegradable polymeric carriers offer 
potential advantages for the prolonged release of low-molecular weight 
compounds to macromolecular drugs. The susceptibility of chitosan to 
lysozyme makes it biodegradable and an ideal drug carrier. Molecules 
such as bovine serum albumin, diphtheria toxoid(DT)4 and 
bisphosphonates5 have been successfully incorporated into chitosan 
microspheres.   
 
 The use of chitosan in injectable preparations has received 
recent attention. Pharmacokinetic and tissue-distribution studies were 
performed in mice using fluorescent glycol-chitosan and N-succinyl-
chitosan. Both chitosan derivatives demonstrated  good retention in the 
blood circulation and a slight accumulation in tissues, suggesting that 
chitosan is an effective carrier for drugs that are excreted rapidly6.  
 
Ocular drug delivery 
 
The poor bioavailability of topically applied ophthalmic drugs implies a 
necessity for frequent instillation to achieve a therapeutic effect. This 
inconvenience could be overcome by a prolonged release of the drug in 
the corneal area. Use of chitosan-based colloidal suspensions in in vivo 
studies showed a significant increase in ocular drug bioavailability7. 
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Gene delivery 
The development of new carrier systems for gene delivery represents 
an enabling technology for treating genetic disorders. However, a 
critical barrier to successful gene therapy remains the formulation of an 
efficient and safe delivery vehicle. Non-viral delivery systems have been 
increasingly proposed as alternatives to viral vectors owing to their 
safety, stability and ability to be produced in large quantities. Some 
approaches employ DNA complexes containing lipid, protein, peptide or 
polymeric carriers, as well as ligands capable of targeting DNA 
complexes to cell-surface receptors on the target cells and ligands for 
directing the intracellular trafficking of DNA to the nucleus. Promising 
results were reported in the formation of complexes between chitosan 
and DNA8. Although chitosan increases transformation efficiency, the 
addition of appropriate ligands to the DNA-chitosan complex seems to 
achieve a more efficient gene delivery via receptor mediated 
endocytosis. Furthermore, incubation of cells with chitosan 
demonstrated low cytotoxic activity9. These results suggest that 
chitosan has comparable efficacy without the associated toxicity of 
other synthetic vectors and can, therefore, be an effective gene-delivery 
vehicle in vivo.     
Nasal drug delivery 
 
There is a growing interest in the development of nasal delivery 
systems for many drugs, including peptides and proteins. To increase 
the bioavailability of these compounds, various absorption enhancers 
have been investigated, including surfactants, bile salts and 
cyclodextrins. However, most of these are associated with side effects, 
such as irreversible changes in the nasal mucosa. Several studies have 
reported the use of chitosan as a safe nasal-delivery system for 
proteins10. Illum et al. have shown that glutamate chitosan can enhance 
the transport of insulin across the nasal mucosa of sheep and rats. The 
efficacy of chitosan as a nasal-absorption enhancer was confirmed 
using salmon calcitonin in a rat model11. 
 
20 
 
Chitosan with antitumor activity 
 
Modified chitosans were reported to display a growth inhibitory effect on 
tumor cells12. This property was employed by Ouchi et al.13 by 
conjugating chitosan or chitosaminooligosaccharide (COS) to 5-
flurouracil (5FU) in order to provide a macromolecular system with 
strong antitumor activities and reduced side effects. Indeed the strong 
antitumor activity exhibited by 5FU is accompanied by undesirable side 
effects. In vivo studies demonstrated that chitosan-5FU conjugate 
exhibited a strong survival effect against lymphocytic leukemia in mice. 
Furthermore, chitosan-5FU and COS-5FU conjugates showed 
remarkable growth-inhibitory effects on Met-A fibro sarcoma and MH-
134Y hepatoma. Both conjugates displayed no acute toxicity, even in 
high dose ranges. Therefore, chitosan-5FU and COS-5FU are expected 
to act clinically as macromolecular prodrugs of 5FU.  
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2.3 Aminopolysaccharides 
Aminopolysaccharides have attracted interest because of the unique properties of 
chitosan which are generally different from those of normal polysaccharides such 
as cellulose14. 
There are two possible strategies, by which amino derivatives of cellulose can be 
synthesized; 
1. Modification of the cellulose polymer itself by regioselective 
introduction of the amino group. 
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Numerous attempts have been made to synthesize aminodeoxycellulose by 
replacing hydroxyl groups by amino groups in order to change the nature of 
cellulose. In 1926 Karrer15 prepared the first aminodeoxycellulose by the reaction 
of cellulose tosylate with ammonia with degree of substitution of 0.1(DS 0.1). 
Figure 7.  Regioselective introduction of amino groups into cellulose  
backbone as a synthetic strategy of aminopolysaccharides  
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 Later Sakurada16 and Scherer and Field17 synthesized aminodeoxycellulose with 
DS of 0.5 and 1.0, respectively.  
Attempts have also been made to synthesize 6-amino-6-deoxycellulose selectively 
by using protecting groups. A common pathway is to prepare 6-O-tritylcellulose 
and protect C-2 and C-3, e.g., by acetyl or phenylcarbamoyl groups. After 
removing the trityl group, the tosyl group is introduced into C-6. The tosyl group is 
used as a leaving group to perform an SN reaction. Haskins and Weinstein18 were 
the first who introduced the phthalimido group into C-6 with a DS of 0.25 by 
previously protecting the C-2 and C-3 positions with acetyl groups. However, they 
failed to remove the phthalic acid residues. In 1973, Usov et al.19 prepared 6-
amino-6-deoxy-2,3-di-O-phenylcarbamoylcellulose with a DS of 0.89 at the 6-
position. Using the same procedure, Teshirogi et al.20 obtained a 6-amino-6-
deoxycellulose derivative with a DS of 0.90.  
 Kern et al.21 synthesized 6-deoxy-6-pyridinium-2,3-di-O-methylcellulose with a DS 
of 0.8 by the reaction of 6-O-tresyl-2,3-di-O-methylcellulose with pyridine in five 
steps. Heinze et al.22 reported on the synthesis of 6-amino-6-deoxycellulose 
derivatives with DS of 0.4–0.6 without using protecting groups. These derivatives 
were obtained by the reaction of cellulose tosylates with (+)-R-, (−)-S- or racemic 
amines, e.g., 1-phenylethylamine in DMF–water.  
6-Azido-6-deoxycellulose and 6-deoxy-6-halocellulose, which are excellent 
intermediates for the preparation of 6-amino-6-deoxycellulose, have also been 
synthesized. Clode and Horton23 reported on a method for the introduction of 
azide into C-6 of cellulose. Two levels of DS (0.25 and 0.68) were achieved after 
having used the above-mentioned activating and protecting group strategy. Saad 
and Furuhata24 obtained 6-chloro-6-deoxycellulose (DS 0.87) and 6-bromo-6-
deoxycellulose (DS 0.92). 6-Deoxy-6-iodocellulose derivatives with a DS in the 
range of 0.46–0.94 were prepared by nucleophilic exchange of cellulose tosylate 
with NaI in acetylacetone.25 However, these 6-deoxycellulose intermediates were 
not used to introduce the primary amino group into C-6. 
Only two groups have reported the synthesis of 6-amino-6-deoxy-cellulose with a 
DS of 0.9 and 1.0. In the first case Teshirogi et al26. prepared 6-amino-6-deoxy-
cellulose using a 6-O-tosylcellulose derivative having protecting groups at C-2 and 
C-3 as an intermediate. In the second case Liu and Bauman27 described the 
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synthesis of 6-amino-6-deoxy-cellulose via 6-O-tosylcellulose derivatives without 
using protecting groups at C-2 and C-3. 
In these two cases, 6-O-tosylcellulose derivatives were used as synthetic 
intermediates for 6-amino-6-deoxycellulose. However, it is well known that the 
regioselective tosylation of cellulose at C-6 with protecting groups at C-2 and C-3 
is difficult, because the tosylation at C-2 and C-3 can occur at the same time13.     
All these attempts show the following disadvantages; 
• Either a low degree of substitution DS 
• Or side reactions on C-2; result in irregular distribution of the amino group. 
Both disadvantages make it difficult to establish a regular structure-properties 
relationship which is desirable for pharmaceutical and technical applications.   
2. The polymerisation of a functionalised sugar monomer. 
By using this strategy the sugar monomer is firstly functionalised. In case of 6-
amino-6-deoxycellulose, the hydroxyl group at C-6 of the sugar monomer is 
substituted to azido group. Secondly the 6-azido-6-deoxy sugar monomer can be 
polymerized to the 6-azido-6-deoxycellulose. Finally the azido groups can be 
reduced to the amino derivatives.  
O
OH
HO
HO
OH
OH
Polymerization Reduction ofAzide to amineSubstitution
O
O
NH2
O
HO
OH
O
HO
NH2
OH
O
O
NH2
O
HO
OH
O
HO
NH2
OH
O
Glucose
6-amino-6-deoxy-cellulose
1 2 3
 
 
 
 
Figure 8. The second strategy for synthesis of aminopolysaccharide starting from functionalized sugar 
monomers 
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Kadokawa et al15. reported the spontaneous polymerisation of 6-amino-6-deoxy-D-
glucose and 2,6-diamino-2,6-dideoxy-D-glucose to the corresponding 
aminopolysaccharides respectively. 
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3. Hydrogels 
 
Hydrogels are the same as aquagels, they are three dimensional network materials 
which do not dissolve in water but able to swell rapidly and retain large volumes of 
water in their swollen structures. Hydrogels are usually made of hydrophilic polymer 
molecules, which are crosslinked, either by chemical bonds or other cohesion forces 
such as ionic interaction, hydrogen bonding, or hydrophobic interaction. Hydrogels 
are elastic solids in the sense that there exists a remembered reference configuration 
to which the system returns even after being deformed for a very long time28. 
 
A hydrogel swells for the same reason that an analogous linear polymer dissolves in 
water to form an ordinary polymer solution29. If a hydrogel, for any reason, dissolves 
in an aqueous solvent, then the gel has become a hydrosol, which is a dispersion of 
colloidal particles in water. From a general physicochemical point of view, a hydrogel 
is simply an aqueous solution. Many polymers can undergo a reversible 
transformation between hydrogel and hydrosol. Chemical crosslinking of dispersed 
particles in hydrosols will result in an irreversible hydrogel. It is noted that a gel is an 
infinitely large macromolecule, or a super macromolecule, which forms a network 
extending from one end to the other and occupying the whole reaction vessel. The 
polymer networks of small particles with diameters smaller than 1 µm (typically in the 
range of 100 nm) are called microgels. Microgels have crosslinked networks just like 
the super macromolecules. Microgels, however, dissolve in water like linear or 
branched macromolecules due to their molecular nature. 
 
The term hydrogel implies that the material is already swollen in water. The dried 
hydrogel is called a xerogel or dry gel. During the drying process water evaporates 
from the gel and the surface tension causes collapse of the gel body. Thus the gel 
shrinks to only a small fraction of its swollen size. If water is removed without 
disturbing the polymer network, either by lyophilization or by extraction without 
organic solvents, then the remaining material is extremely light with porosity as high 
as 98%. Such a dehydrated hydrogel is called an aerogel or sponge. Aerogels are 
known to have lower thermal conductivities than all other thermal insulants at 
ambient conditions. Not all dried hydrogels maintain the ability to swell in water. 
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Ceramics prepared by the sol-gel process are also called xerogels. Xerogels such as 
silica gel will not swell again. To indicate the swelling ability of the dry material, a 
term ‘xerogellant’ was proposed30. There is no lower limit defining how much water a 
material has to absorb to be called a hydrogel. In general, however hydrogels are 
expected to absorb at least 10-20 percent of their own weight in water. If a dried 
hydrogel imbibes at least 20 times its own weight of aqueous fluid while retaining its 
original shape, it is also called a super absorbent. Due to their high water content, 
hydrogels usually have low mechanical strength. 
 
Hydrogels have been a topic of extensive research because of their unique bulk and 
surface properties. Although the research on hydrogels is more than three decades 
old, the research interest in hydrogels is still growing.   
Since the first report on the biomedical use of poly (2-hydroxyethylmethacrylate) 
hydrogel, hydrogels with various properties have been prepared31. Hydrogels can be 
made to respond (i.e., either shrink or expand) to changes in environmental 
conditions and the extent of the response can be controlled. Sometimes the volume 
change in response to the alteration in environmental conditions is so drastic that the 
phenomenon is called volume collapse or phase transition. The environmental 
conditions include pH, temperature, electric field, ionic strength, salt type, solvent, 
external stress, light, and combinations of these. It is these unique properties that 
have made hydrogels find numerous applications in pharmaceutical, agricultural, 
biomedical, and consumer-oriented fields. 
 
• Hydrogel as a Biomaterial 
 
Biomaterials are any type of material, designed to restore, augment, or replace the 
natural functions of the living tissues or organs in the body. Simply speaking, 
biomaterials are those, which become a part of the body either temporarily or 
permanently. Biomaterials are used not only for prosthetic application but also for 
diagnostic and therapeutic applications32. Biomaterials should perform within 
appropriate host response in a specific application without toxic, inflammatory, 
carcinogenic, and immunogenic responses. An appropriate host response ranges 
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from inertness and no interaction to one of positive interaction. In general, the body’s 
reaction to implants is to extrude them from the body or form sheath-like capsules 
around the implants if they cannot be removed.  
The injury created by the implantation procedure usually results in inflammation 
which can be defined as the local reaction of vascularized tissue to injury. The 
implanted biosensors can maintain the required sensitivity only for a few days mainly 
due to inflammation and immune reactions, which decrease the sensor’s sensitivity. 
 Success in the application of biomaterials relies heavily on the biocompatibility 
of biomaterials. Biocompatibility is the appropriate biological performance, both local 
and systemic, of a given polymer in a specific application. A clear, specific, and 
absolute definition of biocompatibility does not exist at this time. Numerous 
interdisciplinary factors must be used to describe the biocompatibility of a given 
polymer in a given application for a given duration. The importance of biocompatibility 
cannot be overemphasized. The recent highly publicized controversy on silicone gel-
filled breast implants is a case in point. The typical tissue reaction around the 
implanted biomaterial is the formation of a thin fibrous capsule similar to scar tissue. 
The fibrous capsule often contracts and causes pain and deformity. The formation of 
a fibrous membrane capsule around the implant is an attempt by the body to extrude 
the implant. Some silicone implants were coated with polyurethane foam featuring 
micropillars, which were designed to disrupt the fibrous capsule architecture and 
prevent the formation of scar tissue. The polyurethane foam, however, was slowly 
degraded in the body. Furthermore, the silicone shell of the implant ruptured in many 
cases releasing silicone gel into the body. Such leakage was blamed for harmful 
immune reactions and for causing cancer. The issue of biocompatibility becomes 
even more important if biomaterials are in contact with blood. Interactions between 
blood and biomaterials may result in thrombus formation, destruction or sensitisation 
of cellular elements in blood, infection, and adverse immune responses. 
 Cumulative evidence shows that hydrogels are highly biocompatible. 
Hydrogels possess a few unique properties that make them biocompatible. First, 
hydrogels have low interfacial tension with surrounding biological fluids and tissues 
and that minimizes the driving force for protein adsorption and cell adhesion. 
Because of its high water content, the hydrogel surface is called a superhydrophilic 
diffuse surface. The superhydrophilic diffuse surface is known to be highly 
28 
 
biocompatible. This is due to the fact that the hydrogel surface makes the actual 
interface more vague. Second, hydrogels simulate some hydrodynamic properties of 
natural biological gels, cells, and tissues in many ways. The high mobility of polymer 
chains at the hydrogel surface contributes to the prevention of protein adsorption and 
cell adhesion. This is mainly due to the steric repulsion resulting from “entropic” and 
“mixing” interactions between the polymer chains and proteins or cell membranes. 
This phenomenon is the same as well-known steric stabilisation of protein molecules 
and colloidal particles. Third, the soft, rubbery nature of hydrogels minimizes 
mechanical and frictional irritation to the surrounding tissue. Low friction surfaces 
cause no pain and no damage to mucous membranes, or mural thrombus formation. 
 A major disadvantage of using hydrogels is that they have poor mechanical 
strength and toughness after swelling. This disadvantage can be overcome by 
grafting a hydrogel with good mechanical properties onto the biomaterial. The 
grafting of hydrogels onto biomaterial surfaces changes only the surface properties 
while the bulk properties remain unchanged. 
Hydrogels can be grafted onto biomaterials by physical adsorption, physical 
entrapment, graft coupling, and polymerisation.  
 The principal markets for biomaterials are in the areas of cardiovascular 
implants, orthopedic implants, intravascular and urinary tract catheters, soft tissue 
replacements, intraocular lenses, wound dressings, biosensors, and controlled 
release devices. All of these biomaterials will improve their biocompatibility through 
coating with hydrogels                        
 
• Biodegradable Hydrogels 
 
Biodegradable polymeric systems have been used frequently in the development of 
advanced drug delivery systems. The use of biodegradable polymeric systems in 
controlled release drug delivery is desirable, since the dosage forms will be degraded 
and eliminated from the body. This will avoid removal of the device from the body by 
surgery or other means when the device is no longer needed. Biodegradable 
polymeric systems also provide flexibility in the design of delivery systems for large 
molecular weight drugs, such as peptides and proteins, which are not suitable for 
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diffusion controlled release through non-degradable polymeric matrices. Our 
impression of biodegradable polymeric systems has changed significantly in recent 
years. When the rate of drug release was mainly controlled by diffusion through the 
polymer matrix, the degradation of the polymer was considered to be a less well-
defined and unnecessary variable. Currently, the degradation of polymer is regarded 
as highly desirable and is frequently used to control the drug release rate. 
 
Most of the research on biodegradable drug delivery systems has employed water-
insoluble polymers such as poly (glycolic acid) or poly (lactic acid). Not much work 
has been done, however, on biodegradable hydrogel systems. Because of the 
unique properties of hydrogels, the biodegradable hydrogels are expected to find 
wide applications in the improvement of existing dosage forms and the development 
of new and better drug delivery systems33. 
In our hands, polymeric products were obtained from 6’-azido-6’-deoxy-cellobiose or 
its derivatives on several occasions. However, so far, attempts to develop suitable 
conditions for the controlled preparation of such polymers have been unsuccessful. 
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4. Immobilised glycans for testing of anti-carbohydrate IgE 
 Protein-linked carbohydrates from plants and insects have different structures 
from those in mammals, thus there is potential for these to be recognised as 
“foreign“. Indeed antibodies raised against plant and insect glycoproteins are often 
directed against the carbohydrate portion of the glycoprotein. One more biomedical 
significance is the finding that patients with allergies towards plant pollens, plant 
foods and insect venoms have antibodies (so-called IgE ) recognising carbohydrate 
epitopes on N-linked oligosaccharides. IgE is of particular importance to allergy 
since, in conjunction with appropriate allergen, cross-linking of IgE receptors leads to 
the release of histamine which causes many of the well-known effects of allergic 
reactions, in the worst case anaphylactic shock. The correct identification of the 
proteins which cause the allergic reactions is a major part of modern allergy research 
and diagnosis. However, since the same carbohydrate structure can be present on 
many proteins, cross-reactions are possible- some of which are clinically significant, 
others only complicating the identification of the relevant allergen. Often recombinant 
proteins are used in the testing of patients' sera and in immunotherapies. For the 
detailed analysis of IgE binding to carbohydrate determinants, practical tools are 
required that permit the coupling in high yields, to carriers such as micro-titre plates, 
of small or trace amounts of glycopeptides isolated and purified from natural sources. 
 
Conventional coupling procedures  
 
Conventional coupling to supports of peptides has been performed by means of 
reactions of the amino-terminal amino group to form Schiff bases with an aldehyde 
function or amide linkages with a carboxylic ester bound to the support. In the 
reductive amination procedure, the initially formed Schiff base is reduced, by the 
action of borohydride, to afford the more stable secondary amine. In amide formation, 
activation of the carboxylic acid can be achieved by means of an ester, activated 
ester such as a hydroxysuccinimide ester or thioester, or lactone. In principle, these 
conventional coupling procedures are well suited if the peptide antigen to be coupled 
is freely available in large amounts. Since the number of binding sites on the micro-
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titre plate is naturally limited, antigen must be applied in excess and of necessity, a 
significant portion of it will be wasted in the course of the coupling procedure. 
Following their release by hydrolytic procedures from allergenic glycoproteins, the 
glycopeptides of interest are part of complex mixtures and may be present in minute 
amounts. In most cases, extensive column-chromatographic purification procedures 
will be required to obtain pure substances for investigations of the molecular details 
of allergenicity. It is therefore essential to develop coupling procedures that avoid 
wastage of the glycopeptides and permit quantitative or near quantitative coupling of 
the materials to the required carriers. 
 
A quantitative reaction is required for the coupling step 
 
Conventional coupling procedures require an excess of the antigen to be coupled. 
However, recent work by Sharpless34 and his associates has demonstrated that 
certain 1,3-dipolar cycloaddition reactions proceed quantitatively with 1:1 
stoichiometry, avoiding the need for excess of one of the reactants. This type of 
efficient reactivity has been termed “click-chemistry”. An example is the dipolar 
cycloaddition of alkynes with alkyl and aryl azides to give 1,2,3-triazoles. This 
reaction has been employed for coupling of antigens to carriers.  
 
Carbohydrate-derived azides as linking arms  
 
Within this work an organic-chemical protocol has been developed, based on a 
conventional protection-deprotection scheme, by which 6-azido-6-deoxy-glucose as 
carbohydrate-derived azide can be obtained in ten steps starting from glucose. 
 
For the purposes of allergen testing the azido sugar can be oxidized to the 
corresponding lactone, this azido lactone can be used in excess, so as to 
quantitatively derivatize the glycopeptides of interest.  Secondly to couple the azido-
glycopeptides, by 1,3-dipolar cycloaddition, to micro-titre plates derivatized with 
alkyne subsituents. 
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The use of carbohydrate-derived azides as linking arms offers several advantages, 
as follows. 
o The aldehyde function of sugars can be oxidized to afford carboxylic acids 
which may be transformed into esters or lactones 
o Azido sugar derivatives are intrinsically more stable than low-molecular weight 
azides such as azidoacetic acid 
o Azido sugar derivatives are easily prepared in practical amounts by 
conventional carbohydrate chemistry. 
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5. Carbohydrate Syntheses 
 
5.1 Chemistry discussion 
 
 
Many complications in the carbohydrate chemistry arise only because of the fact that 
there are many hydroxyl groups on the sugar molecule. The presence of three types 
of hydroxyl groups namely 
- the anomeric hydroxyl group, at C-1 in the case of D-glucose 
- the primary hydroxyl group at C-6 
- the secondary hydroxyl groups which in D-glucopyranose are at C-2, 3, 
and 4. 
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make the ‘free sugars’ very polar in nature, which means they are very soluble in 
polar solvents, especially those that are capable of  H-bonding to these free 
hydroxyls (e.g. water) but completely insoluble in the standard, more non-polar 
solvents used for performing organic reactions, product purification and manipulation 
( e.g. dichloromethane, ether, hexane, toluene etc.). 
 
Another complication arises not only from double character of the anomeric hydroxyl 
which reacts in two ways – as an alcohol or as an aldehyde, but also the process of 
mutarotation allows equilibration of α- and β-hydroxyls at the anomeric position, that 
is, the equilibration of the α-anomer with the β-anomer. Therefore when considering 
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reactivity of the anomeric center as a hydroxyl group we have to bear in mind 
potential competing inter-conversion between these α and β-forms. 
These complications make a regioselective reaction difficult without using protecting 
groups.   
 
Protecting groups  
 
Protecting groups should satisfy several important criteria. First, they should be 
formed in good yield, they should be stable to subsequent reaction conditions, and 
finally, they should be readily removed under appropriate conditions.  
The most commonly used hydroxyl protecting groups are ether and esters protecting 
groups.  
 
 
Sugar hydroxyls react readily as alcohols with activated carboxylic acid derivatives 
such as acid anhydrides, or acid chlorides under appropriate conditions to form the 
corresponding esters. These esters are stable due to the non-nucleophilic characters 
and can bear a wide range of reaction conditions. In addition esters are much less 
polar than the corresponding alcohols. As a result esters are frequently used as 
protecting groups. 
 
 
Acetates are the most commonly used esters. They can be easily prepared by 
stirring the alcohol in a mixture of acetic anhydride and a base. This base not only 
serves to mop up the equivalent of acetic acid that is produced during the reaction 
but it also catalyses the reaction itself. This is necessary since the uncatalysed 
reaction of alcohols with acetic anhydride is very slow at room temperature.  
Acetylation of free sugars can be done in one of three ways, each way has different 
stereochemical consequences for the anomeric position. 
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Acetylation with acetic anhydride and anhydrous pyridine, often used in equal 
proportions as the reaction solvent, at room temperature produces the fully 
acetylated products as a mixture of α/β anomers, which correlate directly to the 
composition of the anomeric mixture in the free sugar starting material. This result is 
due to the fact that under these reaction conditions the acetylation of the free 
hydroxyl at the anomeric centre is faster than the competing process of mutarotation.  
Another way of acetylation is to use acetic anhydride and sodium acetate at 100 °C 
in this case the fully acetylated products are usually the β acetates. This selective 
formation of the β product is due to the fact that at elevated temperatures the 
mutarotation, which leads to α/β equilibration, is much faster than the actual 
acetylation reaction itself. Since the equatorial β hydroxyl is more nucleophilic than 
the axial α counterpart, the β component reacts in preference.  
Acetylation can also be done using acetic acid and Lewis acid catalysis such as zinc 
chloride. Since the α-anomer is thermodynamically favoured by the anomeric effect, 
the predominant reaction product is the α-acetate. 
 
Benzoyl esters (ROBz) are also very commonly used ester protecting groups and 
are readily formed by treatment of the alcohol with benzoyl chloride in the presence 
of an amine base, such as pyridine.  
Acetate and benzoyl ester protecting groups are readily removed by treatment with a 
suitable nucleophile, most commonly methoxide, in a transesterification reaction. 
Selective anomeric deacetylation is also possible under mild conditions using 
copper(II) acetate dihydrate in methanol/ water( 9:1).  
 
Sulfonate esters play also an important role as hydroxyl protecting groups. They are 
also good leaving groups for nucleophilic substitution reactions. The widely used 
sulfonate ester is the toluenesulfonate (tosylate) which is more stable than other 
sulfonate esters. Tosylate esters of the primary hydroxyl group may be selectively 
formed using tosyl chloride in dried pyridine. 
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Ether protecting groups  
 
Benzyl ethers ( ROBn) are commonly used as alcohol protecting groups. Benzyl 
ethers can be easily prepared by reacting the alcohol with benzyl halides, in the 
presence of a strong base such as sodium hydride. Whereas ester protecting groups 
are base-labile, ethers are base-stable. 
  
Trityl ethers, triphenylmethyl(trityl) groups as a result of their bulky nature, they are 
useful for selective protection of the primary hydroxyl group to produce trityl ethers. 
The trityl ethers can be cleaved under mildly acidic conditions to regenerate the 
primary hydroxyl group. Trityl ethers are base-stable.  
 
Acetals 
 
 Cyclic acetals are often used in the carbohydrate chemistry as alcohol protecting 
groups. The benzylidene acetal protecting group is very selective for reaction with the 
4- and 6-hydroxyls of carbohydrates, to form either cis- or trans-fused ring systems. 
The formation of cyclic benzylidene acetals can be achieved by the reaction of 
benzaldehyde with a diol. Since acetal formation is reversible, all the cyclic acetals 
can be easily hydrolysed by treatment with aqueous acid. Therefore the extraction of 
cyclic benzylidene acetals has to be done carefully in alkaline solution. Acetals are 
generally base-stable. 
 
 
Acetonide protection groups are cyclic acetals and result from the condensation of 
two hydroxyl groups of a molecule with acetone. The reaction conditions involve 
treatment of the diol either with acetone itself, or sometimes the dimethyl acetal of 
acetone under acidic conditions. The formed cyclic acetonides are generally 5-ring 
instead of 6-ring, which means the two hydroxyl groups must be cis to one another. 
Where there is possibility of reaction with multiple hydroxyl groups, this usefully 
allows selective access to particular hydroxyl groups of a carbohydrate by selective 
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protection of the cis hydroxyl pairs. The use of acetonide protection in case of D-
glucose makes it possible for selective substitution on the 3-hydroxyl group where as 
the other hydroxyls are acetonide protected.  
 
Nucleophilic substitution reactions  
 
Nucleophilic substitution of sugar hydroxyls takes place if hydroxyls are activated by 
good leaving groups. The treatment of the sugar with tosyl chloride or mesyl chloride 
in the presence of anhydrous pyridine leads to the formation of the corresponding 
tosylate or mesylate respectively. These groups are good leaving groups and allow a 
nucleophilic substitution reaction by an SN2 mechanism. 
  
The azido group can be easily introduced into a carbohydrate via nucleophilic 
displacement of a leaving group such as mesylate or tosylate. These displacement 
reactions are SN2 type. Subsequent reduction of the azide to an amine allows access 
to amino sugars.  
 
Oxidation reactions 
 
Oxidation reactions play an important role in the formation of epimeric sugars. For 
example the oxidation of diacetone glucose with pyridinium chlorochromate 
(C5H6ClCrNO3) or with dimethylsulfoxide leads to the formation of a ketone.  
 
O
O
O
O
O
OH
O
O
O
O
O
O
Benzol /
C5H6ClCrNO3
O
O
O
O
O
HO
NaBH4
Reduction
 
 
38 
 
This ketone can undergo the usual range of reactions. For example the treatment of 
the ketone with a reducing agent such as NaBH4 leads to the formation of the 
corresponding alcohol again with the inversion of the configuration. In case of 
diacetone glucose, the epimer diacetone allose will be formed. 
 
 
Reactions of the anomeric centre   
The anomeric hydroxyl group can act as a nucleophile in simple reactions such as 
acetylation. Conversion of the hydroxyl group at the anomeric position into acetate is 
particularly useful since acetates can readily act as leaving groups under the 
appropriate reaction conditions, and, therefore, many other anomeric substituents 
may be introduced by nucleophilic substitution reactions. 
 
 
Glycosyl halides, such as bromides, are easily prepared by reacting of sugar 
acetates with a solution of HBr in acetic acid. 
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Glycosyl chlorides can be formed analogously, whereas iodides are rather too 
reactive, and due to their high instability have not been used to a great extent in 
synthesis. Glycosyl bromides are the most commonly used halides. They can 
undergo an extremely useful and diverse array of reactions. For example, they can 
react with thiolate anions to form thioglycosides, they can also react with azides to 
form azidoglycosides, which can be reduced to the corresponding glycosyl amine. 
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The reductive elimination of peracetylated glycosyl bromides leads to the formation of 
glycals.  
 
Oxidation  
The anomeric center can undergo oxidation reactions to the carboxylic acid. This can 
be done selectively using bromine in water. The product can either be isolated as the 
acid salt, or, if the reaction is performed under mildly acidic conditions, then, as the 
corresponding lactone. 
 
Reduction 
 
Treatment of sugars with good reducing agents, such as sodium borohydride 
produces the open chain alditol in good yield. These reduction reactions proceed via 
reduction of the small amount of open chain aldehyde in solution with, once again, 
the corresponding shift in equilibrium.  
 
Chemical disaccharide formation 
 
Chemical disaccharide formation is known as glycosylation reaction in which a 
glycosidic bond is formed by the displacement of a leaving group at the anomeric 
position of one sugar, termed the glycosyl donor, with the free hydroxyl group of 
another, itself termed the glycosyl acceptor. The bond formed between the donor and 
acceptor is called glycosidic bond. 
 
Glycosyl acceptors 
 
Due to the nucleophilicity of different hydroxyls around a sugar ring, a regioselective 
glycosylation reaction is not possible without selective protection of the hydroxyl 
groups,   and a mixture of glycosylation products is to be expected. This problem can 
be overcome by selective protection of the glycosyl acceptor.  Hence most glycosyl 
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acceptors are monosaccharides that only have a single free hydroxyl group. The 
anomeric position of a glycosyl acceptor should be suitably protected or differentially 
functionalised from the anomeric position of the glycosyl donor to hinder a self 
reaction and/or polymerization. 
 
Glycosyl donors  
 
A glycosyl donor is the other reactant of a glycosylation reaction, in which the leaving 
group at the anomeric position is displaced by the free hydroxyl group of the glycosyl 
acceptor. The activation of the anomeric leaving group is necessary in order to 
achieve this displacement. On activation not only the substituent at the anomeric 
center of the gylcosyl acceptor must remain unaffected but also any other existing 
glycosidic linkages, be they in the donor or acceptor. 
 
Glycosyl bromides  
 
Glycosyl bromides are widely used as glycosyl donors. They were the first glycosyl 
donors used for disaccharide formation by Königs and Knorr. They can be activated 
by the addition of halophiles such as silver salts e.g. soluble silver triflate or 
perchlorate (AgOTf or AgClO4), or such soluble mercury salts (e.g. Hg (CN) 2 or 
HgBr2) or. Glycosyl bromides are easily formed by treatment of a sugar acetate with 
a solution of HBr in acetic acid.  
 
Glycosyl fluorides 
 
Glycosyl fluorides are much more stable than the corresponding bromides and 
chlorides. They can be readily synthesized from the corresponding thioglycosides by 
treatment with diethylaminosulfur trifluoride (DAST, Et2NSF3). 
 
 
41 
 
Thioglycosides  
 
Thioglycosides are most commonly used as glycosyl donors. They are readily 
prepared from the corresponding anomeric acetates by treatment with a thiol and a 
lewis acid, such as boron trifluoride etherate (BF3.Et2O). Thioglycosides are more 
stable than glycosyl bromides, and will not react until they are activated under 
particular reaction conditions for example using activating groups such as N,N-
dialkylsulfinamide and trifluoromethanesulfonic anhydride (Tf2O)35. 
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5.1.1  Synthesis of 6'-azido-6'-deoxy-cellobiose 
(Scheme 1) 
 
The use of cellobiosyl fluorides as precursors for the in vitro enzymatic synthesis of 
cellulose has given cellobiose derivatives more attention to be used as substrates for 
the same catalytic reaction. Important cellobiose derivatives are those which carry 
azido groups. The azido group serves for introduction of nitrogen, functions as a 
protecting group for nitrogen, and, being electrically neutral, is frequently compatible 
with enzyme-catalyzed reactions.  
There are theoretically 6 positions on the cellobiose molecule where we can 
introduce an azido group, namely C-2, C-3 and C-6 of the reducing glucose unit and 
analogous positions of the non-reducing glucose unit. Within this work we have 
synthesized two cellobiose azido derivatives, in which the azido function is located at 
the C-6 position of the reducing or the non-reducing sugar unit(C-6’). 
  
6'-Azido-6'-deoxy-cellobiose was synthesized from cellobiose in twelve steps. Briefly,    
cellobiose was first completely acetylated with acetic anhydride in pyridine to form 
the octaacetate derivative of cellobiose. Then the anomeric position was activated by 
the formation of the corresponding glycosyl bromide by treatment of the cellobiose 
octaacetate with a solution of HBr in acetic acid, to form exclusively the 
thermodynamically favored α-anomer36. Recrystallisation from a mixture of 
tetrahydrofuran and diisopropylether has offered the formed glycosyl bromide extra 
stability. The crystalline glycosyl bromide is then treated with allyl alcohol under 
catalysis by Hg (CN)2 in dried dichloromethane. The formed allyl-β-D-cellobiose 
derivative was then deacetylated with sodium methoxide in methanol (Zemplén 
deacetylation) to give the free allyl-β-D-cellobiose. A regioselective protection of the 
4',6'-hydroxyls was carried out using benzaldehyde under the catalytic action of zinc 
chloride. The formed 4',6'-benzylidenated β-allyl glycoside was directly acetylated. 
Heating at reflux in 60% acetic acid resulted in the deprotection of 4' and 6' positions. 
The formed β-allyl glycoside of cellobiose contains only 2 free hydroxyls at C-4' and 
43 
 
C-6'. Selective 6'-O-mesylation followed by per-O-acetylation afforded the 6'-O-
mesylated derivative of cellobiose glycoside. 
Treatment of the mesylate derivative with sodium azide in dimethyl formamide at 
120°C has introduced the azido group in the six position of the non-reducing sugar 
unit. Finally the anomeric allyl group was removed by the action of palladium chloride 
and sodium acetate in acetic acid-water mixture. Further deacetylation with 
methoxide in methanol afforded the 6'-azido-6'-deoxy-cellobiose.  
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5.1.2  Synthesis of 6-azido-6-deoxy-cellobiose37 
(Scheme2) 
In a similar protocol 6-azido-6-deoxy-cellobiose was also synthesized from cellobiose 
in twelve steps. First, the cellobiose was peracetylated with acetic anhydride in 
pyridine, followed by treatment with HBr in acetic acid that converted the anomeric 
acetate to the corresponding glycosyl bromide. The anomeric position was then 
protected through the formation of allyl glycoside38 on treatment of the glycosyl 
bromide with allyl alcohol. Deacetylation of the allyl glycoside with methoxide in 
methanol   and regioselective protection of the 4’,6’-hydroxyl groups by the action of 
benzaldehyde, catalyzed by zinc chloride, the 4’,6’-benzylidenated β-allyl glycoside of 
cellobiose was obtained, containing only one free primary hydroxyl function at C-6. 
Selective 6-O-mesylation followed by per-O-acetylation and treatment with sodium 
azide in dimethyl formamide at 100°C afforded the 6-azido-6-deoxy-cellobiose 
glycoside, in which the azido group was introduced into the C-6 of the reducing sugar 
unit.  Deprotection of the benzylidene group was achieved by reflux with 60% acetic 
acid, followed by ester protection (with acetic anhydride/ pyridine). The anomeric allyl 
group was then removed by palladium chloride and sodium acetate in acetic acid-
water. Finally, deacetylation with sodium methoxide in methanol afforded 6-azido-6-
deoxy-cellobiose.           
            
            
            
            
            
            
            
            
            
            
            
             
46 
 
 
O
O
HO
HO
OH
OH OH
OH
OHHO
O
AcOAc / Pyridin O
O
AcO
AcO
OAc
OAc OAc
OAc
AcO
O
OAc
HBr / HOAc
O
O
AcO
AcO
OAc
OAc OAc
AcO
AcO
O
Br
Hg(CN)2 / AllOH O
O
AcO
AcO
OAc
OAc OAc
AcO
AcO
O
O
O
O
HO
HO
OH
OH OH
OH
HO
O
O
NaOMe/MeOH
O
OHO
OH OH
OH
HO
O
OO
OPh
 PhCHO / ZnCl2
O
OHO
OH OMs
OH
HO
O
OO
OPh
MsCl / Pyridin
O
OAcO
OAc
OAc
AcO
O
OO
OPh
OMs
AcOAc / Pyridin
O
OAcO
OAc N3
OAc
AcO
O
OO
OPh
NaN3 / DMF
O
OAcO
OAc N3
OAc
AcO
O
OHO
HO
AcOH AcOAc / Pyridin
O
OAcO
OAc N3
OAc
AcO
O
OAcO
AcO
PdCl2 / NaOAc
AcOH / H2O
O
OAcO
OAc N3
OAc
AcO
O
OHAcO
AcO
NaOMe/MeOH
O
OHO
OH N3
OH
HO
O
OHHO
HO
6-Azido-6-deoxy-cellobiose
Cellobiose
Synthesis of 6-azido-6-deoxy-cellobiose
1 2
3 4
5 6
14 15
16 17
18 19
20
 
 
 
 
Scheme 2 
47 
 
 
5.1.3  Synthesis of 6-azido-6-deoxy-D-glucose 
(Scheme 3) 
6-Azido-6-deoxy-D-glucose is obtained from glucose by a conventional protocol in 10 
steps39. D-glucose was peracetylated by acetic anhydride in pyridine. The anomeric 
acetate was then activated through the formation of the corresponding bromide 
glycoside. This was done by reacting the glucose pentaacetate with HBr in acetic 
acid. The formed glycosyl bromide was then recrystalized from diisopropyl ether. The 
white crystals of the α-bromo glycoside were stable over several months. Protection 
of the anomeric position was easily done by reacting the glycosyl bromide with allyl 
alcohol under catalysis by mercuric cyanide in dichloromethane. After deacetylation 
with methoxide in methanol, the formed free allyl glycoside, containing one primary 
hydroxyl at C-6, was selectively O-mesylated. The temperature was kept at -30° 
using a dry ice bath in order to minimize any side products on the other hydroxyls. 
Per-O-acetylation was performed to protect the hydroxyls on C-2, C-3 and C-4. The 
mesylate derivative was then refluxed for 2 hours with sodium azide in dimethyl 
formamide to give the corresponding azido derivative. Deprotection of the allyl group 
was carried out using palladium chloride and sodium acetate in acetic acid-water 
mixture. Finally, deacetylation afforded the 6-azido-6-deoxy-D-glucose.       
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5.1.4  Synthesis of 3-azido-3-deoxy-D-glucose 
 
(Scheme 4) 
3-Azido-3-deoxy-D-glucose was synthesized from the commercially available 1,2:5,6-
di-O-isopropylidene-α-D- glucofuranose in 5 steps. In the first step the protected α-D-
glucofuranose was oxidized with acetic anhydride in dimethyl sulfoxide at 70°C to 
give the hexofuranose analogue. The hexofuranose derivative was then reduced with 
sodium borohydride in ethanol as a solvent to give the allofuranose derivative. The 
allofuranose derivative was then O-mesylated in the free hydroxyl group at C-3 to 
give the 3-O-mesylate derivative. The mesyl group was then substituted with azido, 
through the reaction with sodium azide in DMF. Under gently heating the protecting 
groups were removed with Dowex® H+ to give the 3-azido-3-deoxy-D-glucose. 
 
 
 
 
5.1.5   Synthesis of β-D-allose 
(Scheme 5) 
The synthesis of β-D-allose was simply achieved by the action of Dowex® H+ resin on 
allofuranose (compound 33) in water under gentle heating. In this reaction the two 
isopropylidene protecting groups were removed40. 
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5.2 Enzyme-Catalyzed Syntheses 
 
5.2.1  Carbohydrate Processing Enzymes 
 
The chemical formation of a particular glycosidic bond involves the consideration of 
three factors: 
• Reactivity 
• Regioselectivity 
• Stereoselectivity 
 
Despite the development of a number of chemical techniques that allow partial 
control of the configuration at the anomeric center, these methods are rarely general. 
As a result, mixtures of products are often formed that require laborious purification. 
The formation of side products with the "wrong" stereochemistry also lowers the 
yields of the desired products. Enzymes are powerful catalysts that are able to 
overcome some of these problems. They contain a region which is called the active 
site, that control the reaction they catalyse, this active site can be considered as 
made of two parts: the catalytic site, which increases the rate of the reaction, and the 
binding site or sites which hold(s) the reactants in place and determines the 
selectivity of the reaction. 
The mechanistic action of carbohydrate processing enzymes can be understood in 
the terms of the problems of gycosidic bond formation as follows. 
 
1. Reactivity – just for chemical methods of forming glycosidic bonds, 
enzymatic mechanisms also rely on the loss of a good leaving group from the 
anomeric centre of the glycosyl donor. This bond breaking is typically assisted 
by the involvement of the lone pair on the ring oxygen atom and leads to the 
53 
 
formation of a glycosyl cation intermediate. The transition state that leads to 
the formation of this reactive intermediate is stabilised by the catalytic site of 
the enzyme. As the formation of this transition state is the lowest step, 
lowering the associated energetic barrier causes an increase in the rate of 
reaction. The shape of the binding site of the enzyme now holds this reactive 
species ready for attack by a nucleophile such as the hydroxyl group of 
another sugar, the glycosyl acceptor. 
 
 
2.  Regioselectivity - because the reactants fit perfectly into the binding sites of 
the enzyme in only one particular orientation, the shape of the enzyme 
determines which groups will react. Both the glycosyl acceptor and glycosyl 
donor are held tightly in the enzyme's binding site. Their relative orientations 
allow the reaction of only one of the hydroxyl groups of the acceptor. The 
other hydroxyl groups of the glycosyl acceptor are buried in the folds of the 
binding site; they are therefore temporarily protected and so do not react. 
Furthermore, the reactive anomeric carbon atom in the glycosyl donor is close 
enough to only one particular hydroxyl group to react. 
 
 
3. Stereoselectivity – The enzyme also binds the reactive glycosyl donor in 
such a way that it can only be attacked from one side: either above or below. 
The result is that the formation of only one stereochemical configuration is 
possible. Which configuration is formed therefore depends on the shape of 
the enzyme active site. Different enzymes have evolved with differently 
shaped active sites; some allow only the formation of α products whilst some 
will catalyze formation of only the β-glycosides.  
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5.2.1.1 Cellulase enzyme system 
All cellulases hydrolyze41 the ß-1, 4-glucosidic bond between glucosyl moieties by a 
general acid catalysis requiring a proton donor and a nucleophile/base. The 
hydrolysis products can either result in the inversion or retention (double replacement 
mechanism) of the anomeric configuration of carbon-1 at the reducing end42. The 
enzymes have a complex molecular architecture comprising discrete modules: the 
catalytic domains are joined to non-catalytic modules, called carbohydrate binding 
modules (CBM), by linker regions (commonly proline-threonine-serine- or PTS-
boxes). 
Cellulases differ not only in the action mode (endo or exo), but also in the way they 
bind to the crystalline surface of the substrate. The crystalline material is hydrolyzed 
by a number of simultaneously present, interacting enzymes, or alternatively by a 
multienzyme complex. Only by cooperation with non-catalytic specific binding 
modules (the carbohydrate binding proteins or modules), the enzymes are able to 
disrupt the crystal surface at the solid-liquid interphase, to make single cellulose 
fibers accessible for hydrolysis. 
Endoglucanases cut at random at internal amorphous sites in the cellulose 
polysaccharide chain, generating oligosaccharides of various lengths and 
consequently new chain ends. Exoglucanases act in a processive manner on the 
nonreducing ends of cellulose polysaccharide chains, liberating either glucose 
(glucanohydrolases) or cellobiose (cellobiohydrolase) as major products. 
Exoglucanases can also act on microcrystalline cellulose, presumably peeling 
cellulose chains from the microcrystalline structure. ß-Glucosidases hydrolyze soluble 
cellodextrins and cellobiose to glucose. Cellulases are distinguished from other 
glycoside hydrolases by their ability to hydrolyze ß-1, 4-glucosidic bonds between 
glucosyl residues. The enzymatic breakage of the ß-1, 4-glucosidic bonds in cellulose 
proceeds through an acid hydrolysis mechanism, using a proton donor and 
nucleophile or base.  
A general feature of most cellulases is a modular structure often including both 
catalytic and carbohydrate-binding modules (CBMs) as shown in Figure 9. The CBM 
effects binding to the cellulose surface, presumably to facilitate cellulose hydrolysis 
by bringing the catalytic domain in close proximity to the substrate, insoluble 
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cellulose. The presence of CBMs is particularly important for the initiation and 
processivity of exoglucanases43. 
 In Figure 9 the solid squares represent reducing ends and the open squares 
represent nonreducing ends. Amorphous and crystalline regions are indicated.  
 
 
 
 
 
Cellulase systems are not merely an agglomeration of enzymes representing the 
three enzyme groups (endoglucanases, exoglucanases, and ß-glucosidases, with or 
without CBMs), but rather act in a coordinated manner to efficiently hydrolyze 
cellulose. Microorganisms have developed different approaches to effectively 
hydrolyze cellulose, naturally occurring in insoluble particles or imbedded within 
hemicellulose and lignin polymers. 
 
Figure 9. Schematic representation of the hydrolysis of amorphous and microcrystalline cellulose 
 by noncomplexed (A) and  complexed (B) cellulase systems[41]. 
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A schematic representation of cellulase action 
 
The catalytic activity of the cellulase enzyme system can be summarized in the 
following steps  
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Endoglucanase EG binds randomly to the surface of the cellulose microfibril. The 
catalytic action of EG breaks a glycosyl bond within a glucan chain. 
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EG leaves the microfibril surface, the nick in the glucan chain exposes a reducing 
and nonreducing end. 
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Cellobiosylhydrolase CBH (which is an exoglucanase) can act only on the free 
nonreducing end of a glucan chain. The catalytic action of CBH cleaves a cellobiose 
unit from the nonreducing chain end.  
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Cellobiose is released into solution, where it is split into glucose monomers by β-
glucosidase β-G or by cellobiose phosphorylase (see page 61).  
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CBH moves to the newly created free nonreducing end and continues to cleave 
cellobiose units from the glucan chain. EG continuously nicks glucan chains but 
releases little soluble reducing sugar. CBH is catalytically active only at glucan chain 
ends. Thus, EG created sites at which CBH may act. The result is synergistic 
degradation of cellulose.  
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Reversal of cellulase action 
 
The use of cellulase enzyme as a catalyst for the synthesis of complex 
polysaccharides has played an important role in polymer synthesis. One example is 
the first successful in vitro synthesis of cellulose via a nonbiosynthetic pathway by 
utilizing cellulase as a catalyst, where the enzymatic synthesis of cellulose can be 
achieved via polycondensation of β-cellobiosyl fluoride monomer44,45,46  (Figure10). 
Thereby it was postulated that a cellobiose unit would be preferable as a substrate 
because it can be recognized by the binding site of the enzyme more readily than a 
glucose derivative. For this transglycosylation reaction β-cellobiosyl fluoride was 
chosen as activated glycosyl donor.  
 
 
 
 
The cellulase promotes the transglycosylation of the cellobiose moiety toward the 4’ 
hydroxy group of another monomer, eliminating hydrogen fluoride. The 
polymerization has to be carried out in an aqueos organic solvent system e.g. 
acetonitrile and acetate buffer in order to make the desired polycondensation 
predominant over the competitive hydrolysis reaction. The configuration of the C1 
fluorine atom of the starting material has been designed in order to form a reactive 
intermediate leading to a β (1→4) product via “double displacement mechanism” at 
the active site of the enzyme. 
 
Figure 10: Synthetic route of β-cellobiosyl fluoride monomer  
from cellobiose octaacetate [46] 
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The experimental procedure for the enzymatic polymerisation is as follows. In a test 
tube a solution of Trichoderma viride is added to a solution of β-cellobiosyl fluoride 
monomer in a mixed solvent of acetonitrile/acetate buffer. The addition of acetonitrile 
is essential for the cellulase catalyst to promote the reverse reaction of the hydrolytic 
decomposition47. The polymerisation perfectly controls the regio- and 
stereochemistry of the reaction, giving rise to the synthetic cellulose (degree of 
polymerisation < 22). Alternatively, under the reaction conditions of a higher 
substrate concentration or higher acetonitrile concentration, water-soluble cello-
oligomers (degree of polymerisation < 8) are produced predominantly. After 
inactivating the enzyme, the reaction mixture is purified, yielding a water-insoluble 
white powdery material, the synthetic cellulose and a mixture of cello-oligomers. 
 Figure 12 shows the flow chart for the preparation of synthetic cellulose (the water-
insoluble part) as well as cello-oligomers (the water-soluble part). 
 
 
 
Figure 11: The enzymatic polymerisation of β-cellobiosyl fluoride monomer  
catalysed by cellulase in acetonitrile-buffer [46] 
Figure 12: Flow chart for the preparation of synthetic cellulose [46] 
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5.2.1.2 Glucose Oxidase 
 
Glucose oxidase (β-D-glucose:oxygen 1-oxidoreductase, EC1.1.3.4) catalyses the 
oxidation of β-D-glucose to D-glucono-1,5-lactone and hydrogen peroxide, using 
molecular oxygen as the electron acceptor48. 
 
 
 
Glucose oxidase has been used in the food industry for the removal of glucose from 
powdered eggs and for a source of hydrogen peroxide in food preservation. 
Moreover, it is also used for quantitative determination of D-glucose in blood, food 
and fermentation products and enzyme-antibody conjugates for enzyme 
immunoassays49.  
Glucose oxidase is a flavin-containing glycoprotein. The enzyme is a homodimer, 
composed of two subunits; the monomer folds into two structural domains (Figure13). 
One of the domains binds FAD noncovalently and the other is involved with substrate 
binding. The FAD is acting as a redox carrier in catalysis and can be released from 
the holoprotein after denaturation50. FAD functions as a coenzyme owing to its ability 
to undergo reversible redox reactions.   
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Overall Reaction Mechanism 
The enzymatic oxidation of glucose proceeds in two steps, the reductive half reaction 
in which two protons and electrons are transferred from β-D-glucose to the FAD. This 
step of the catalytic cycle leads to the oxidation of β-D-glucose to δ-gluconolactone. 
 
In the second step, the oxidative half reaction, the enzyme is oxidized by molecular 
oxygen yielding hydrogen peroxide. 
Figure13: High resolution crystal structure of GOX:  A) overall topology of holoenzyme 
 B) Subunit structure of GOX showing FAD (red space fill) 
M.  Cardosi, Electrochemical Sensors Group, University of Paisley, Paisley,  Scotland 
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Finally δ-gluconolactone can be hydrolyzed non-enzymatically to gluconic acid. This 
hydrolysis step is pH depentant. 
 
 
The redox active centre of the FAD coenzyme is the isoalloxazine ring system as 
shown in Figure14  
 
Figure14: Chemical structure of the coenzyme FAD 
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The reaction sequence below shows the transfer of two electrons and two hydrogen 
atoms to the isoalloxazine ring system during the process. This electron and 
hydrogen transfer leads to the reduction of riboflavin to dihydroriboflavin.   
 
Under reaction with molecular oxygen the dihydroriboflavin (FADH2) can be 
reoxidized to the hydroperoxy intermediate. The later gives under loss of hydrogen 
peroxide the FAD again.  
Substrate Specificity of glucose oxidase GOX 
Glucose oxidase has affinity toward different sugars such as D-xylose, D-mannose, 
D-galactose and glucose analogs such as 2-deoxyglucose. The rate of reaction of 
glucose oxidase with β-D-glucose is very much faster than that with other sugars51. It 
was also reported that α-hydroxycarbonyl compounds such as dihydroxyacetone, 
glyceraldehyde, phenacyl alcohol, and furoin are also substrates for glucose oxidase, 
acting as glucose analogs52. 
6-Azido-6-deoxy-D-glucose as substrate 
Within this work we have synthesized 6-azido-6-deoxy-D-glucose, it was investigated   
as an analog of glucose to act as a substrate for glucose oxidase. Under the 
optimum reaction conditions, we could not detect any product formed or any change 
in the educt. Other investigations may needed to explain either the enzyme-substrate 
complex is not formed at all, or if the azido group in the six position of the glucose 
may inhibit the formation of stable intermediate.     
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5.2.1.3 Cellobiose Dehydrogenase 
Cellobiose dehydrogenase (CDH) is an extracellular flavocytochrome containing flavin 
and b-type heme, and plays a key role in cellulose degradation by filamentous fungi53. 
In filamentous fungi, cellulose degradation had been thought to proceed via two-step 
hydrolysis, i.e. cellulose is hydrolyzed to cellobiose by various cellulases and the 
product is further hydrolyzed to glucose by β-glucosidase. However, recent 
cytochemical, kinetic, and transcriptional studies have supported another hypothesis 
concerning the contribution of cellobiose dehydrogenase to the extracellular cellulose 
metabolism of the white-rot fungus Phanerochaete chrysosporium, and the importance 
of a combination of hydrolytic and oxidative reactions in cellulose-degrading fungi. 
CDH is the only extracellular flavocytochrome known to be secreted by filamentous 
fungi during cellulose degradation. This enzyme carries flavin and a b-type heme in 
different domains and the flavin domain catalyzes the dehydrogenation of cellobiose 
and cello-oligosaccharides to the corresponding δ-lactones. Although this enzyme was 
initially characterized as an oxidase (cellobiose oxidase), its higher affinity for 
quinones and ferric compounds than for oxygen and the low-spin character of the 
heme in both the ferric and ferrous states indicate that the electron acceptor of this 
enzyme is not molecular oxygen. Although many candidates have been proposed for 
the electron acceptor of CDH, its natural electron acceptor and the physiological 
function of the oxidative half reaction of this enzyme are still uncertain. CDH displays54 
the properties of a typical dehydrogenase with oxidative and reductive half reactions 
that can be studied separately. The oxidative half reaction represents an oxidation in 
the C1 position of a saccharide;  
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Figure 15. The oxidative half reaction of CDH. CDH performs a two-electron oxidation of the C1 of 
cellobiose to a lactone.The electrons are taken up by the FAD of CDH. The lactone will spontaneously 
hydrolyze under ring opening to a carboxylic acid [54] 
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the hemiacetal at this position is converted into a lactone that hydrolyzes 
spontaneously to a carboxylic acid (cellobionic acid) (Fig. 15). The two electrons taken 
up by the enzyme are later transferred further to one two-electron acceptor, or to two 
one-electron acceptors. 
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5.2.1.4 Cellobiose phosphorylase 
 
Cellobiose phosphorylase (CBP) is one of the phosphorolytic enzymes that catalyze 
the reversible phosphorolysis of cellobiose to form glucose and α -D-glucose-1-
phosphate, with an inversion of the anomeric configuration.  
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O
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HO
HO
OH
OH OH
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O
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OH
OH OH
 
 
The cellobiose phosphorylase of Clostridium thermocellum is an endocellular enzyme 
responsible for the reversible phosphorolysis of cellobiose.  
 
 
 
The physiological role of cellobiose phosphorylase is to convert cellobiose into α-D-
glucose-1-phosphate (G-1-P), which is more efficiently utilized as a carbon source 
than D-glucose in some microorganisms55. It plays an important role in cellulose 
breakdown56.  
 
Figure 16. A model of Clostridium thermocellum cellulosomes and an 
associated cell-surface anchoring protein 
 
Schwarz WH, Research Group Microbial Biotechnology, TU München, Germany(2001) 
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Cellobiose phosphorylase has been shown to catalyze the synthesis of a number of 
Glc-β- (1→4) linked disaccharides from glucose-1-phosphate and various glycosyl 
acceptors. The reversible phosphorolysis reaction requires the acceptor to maintain 
the configuration of β-D-Glc-P at the C-1 and C4 positions, although the 
configurations of the C-3 and C-5 positions can also be important. Comparison of the 
data for 6-deoxy and 2-deoxyglucose showed that the role of the hydroxyl group at 
C-6 is less critical than that of the hydroxyl group at C-2. Kinetic data suggests that 
the hydroxyl group at the C-6 plays a role in enzyme-substrate binding57.  
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Synthesis using the reversible reaction of phosphorylases is advantageous over 
other enzymatic methods, such as the transglycosylation reaction of glycosidases, 
due to the regioselectivity of the enzyme resulting in only one product and because of 
the ready availability of donor substrate54. Cellobiose phosphorylase can also utilize 
disaccharides as acceptors to form trisaccharides. The exclusive formation of a β 
(1→4) branch on the reducing residue of the (1→6)-linked disaccharides confirms the 
specificity of cellobiose phsophorylase and explains why cellobiose phosphorylase 
did not react with the non-reducing residues of the disaccharides55.       
 
 
Cellobiose phosphorylase catalysis 
 
Beside the use of organic-chemical protocols based on conventional protection-
deprotection schemes, we have also used enzyme-catalyzed synthetic protocols. 
Firstly the cellobiose phosphorylase enzyme was tested for its ability to use azido 
sugars as substrates for both synthetic as well as phosphorolytic actions. Cellobiose 
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phosphorylase (CBP) is one of the phosphorolytic enzymes that catalyze the 
reversible phosphorolysis of cellobiose to form glucose and α-D-glucose1-
phosphate, with an inversion of the anomeric configuration. 
 
 
 
Phosphorylation reactions 
 
From the cellobiose series we have tested both 6-azido-6-deoxy-cellobiose and 6'-
azido-6'-deoxy-cellobiose as substrates for the phosphorolytic reactions. The 
incubation of each substrate was done at 37°c with the enzyme extract in phosphate 
medium as buffer of PH 7.0.  
    
The general equation of the phosphorylitic reaction is as follows. 
 
The enzyme breaks the β (1→4) glycosidic bond of cellobiose to give glucose 1-
phosphate and D-glucose as products. 
In the case of 6-azido-6-deoxy-cellobiose, the same β (1→4) glycosidic bond was 
broken and has given glucose-1-phosphate and 6-azido-6-deoxy-D-glucose 30 as 
products. In this example we have shown an alternative synthetic pathway for 6-
azido-6-deoxy-glucose using enzymatic route.   
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In the case of 6'-azido-6'-deoxy-cellobiose it was expected to get 6-azido-6-deoxy-α-
D-glucose1-phosphate and D-glucose as products. However our investigations did 
not give any identifyable products. Further investigations may be needed to ascerain 
if the azido group at C-6 of the non-reducing sugar unit is incompatible with the 
catalytic action of the enzyme. 
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Reversal reaction of cellobiose phosphorylase 
 
In the reverse reaction, CBP catalyzes the production of heterodisaccharides from 
various derivatives of glucose. The general equation of the reversal reaction of CBP 
is as follow;  
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We have investigated the following derivatives. 
I) 6-azido-6-deoxy-D-glucose 
II) 3-azido-3-deoxy-D-glucose 
III) β-D-allose 
 
I) Enzymatic synthesis of 6-azido-6-deoxy-cellobiose: 
 
6-Azido-6-deoxy-D-glucose 30 was used as substrate in the reversal phosphorylase 
reaction to synthesize the corresponding disaccharide. The incubation was done at 
37°C for 24 h in Tris buffer as medium. The progress of the reaction was detected by 
TLC. The following equation describes the enzymatic catalysis of disaccharide 
formation. 
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The TLC in the Figure 17 shows the formation of 6-azido-
6-deoxy-cellobiose 20 in the reverse reaction, in which 
glucose-1-phosphate reacted with 6-azido-6-deoxy-D-
glucose under the catalytic action of cellobiose 
phosphoryalse in tris buffer, as well as the formation 6-
azido-6-deoxy-D-glucose in the forward phosphorylation 
reaction, in which 6-azido-6-deoxy-cellobiose is 
phosphorylated in the presence of phosphate buffer to give 
glucose-1-phosphate and 6-azido-6-deoxy-D-glucose 30 . 
 
II) 3-Azido-3-deoxy-cellobiose 
 
Hypothetically the reversed action of cellobiose phosphorylase on 3-azido-3-deoxy-
D-glucose could lead to the formation of the corresponding disaccharide according 
to this equation; 
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Figure 17 
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We have incubated glucose-1-phosphate and 3-azido-3-deoxy-D-glucose with the 
cellobiose phosphorylase in Tris buffer for 24 hours at 37°c. The TLC did not show 
any noticeable changes. This means the introduction of azido group in the 3 position 
of glucose is incompatible with the synthetic action of the enzyme. 
 
III) β-D-Allose 
 
The inverted configuration of only one stereocentre on β-D-allose gives the molecule 
similarity to that of D-glucose. Hypothetically it could act as a substrate for the 
cellobiose phosphorylase to yield a cellobiose derivative. 
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After the incubation of β-D-allose with glucose-1-phosphate in the presence of 
cellobiose phosphorylase in Tris buffer, the TLC did not reveal any products. That 
means either the equatorial configuration of the hydroxyl on C-3 is essential for the 
substrate-enzyme binding, or that the axial orientation of the hydroxyl group inhibits 
the binding. 
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5.2.1.5 Cellobiose dehydrogenase catalyzed synthesis 
6'-Azido-6'-deoxy-cellobiose 13 and 6-azido-6-deoxy-cellobiose 20 were tested for 
their ability to act as substrates for cellobiose dehydrogenase CDH. Cellobiose 
dehydrogenase oxidizes cellobiose to cellobionolactone. The following reaction 
equation describes this oxidation; 
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Compounds 13 and 20 as well as cellobiose 1 were incubated with CDH in the 
presence of potassium hexacyanoferrate K3 [Fe (CN) 6] at 30°c.The progress of the 
reaction was detected using TLC. 
 
 
 
 
 
 
 
 
 
 
 
 
The oxidative half reaction of CDH. CDH performs a two-electron oxidation of the C-1 of 
cellobiose to a lactone.The electrons are taken up by the FAD of CDH. The lactone will 
spontaneously hydrolyze under ring opening to a carboxylic acid. 
Figure 18. Oxidation of CLB, CLB-6-N3 and CLB-6'-N3 with cellobiose dehydrogenase 
1= cellobiose,  2= cellobiose-6-N3   and 3= cellobiose-6'-N3 
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After 2 h the oxidation of cellobiose was completely finished, whereas that for 6'- 
azido-6'-deoxy-cellobiose and for 6-azido-6-deoxy-cellobiose required longer than 24 
hours.  
 
 
Scheme of the oxidation reactions 
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Oxidation of cellobiose, 6-azido-6-deoxy-cellobiose and 6’-azido-6’-deoxy-cellobiose  
with cellobiose dehydrogenase 
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5.3. Alkyne-azide coupling; 1,2,3-Triazoles formation 
 
Click chemistry is a newer approach to the synthesis of drug-like molecules that can 
accelerate the drug discovery process by utilizing a few practical and reliable 
reactions. Sharpless and coworkers defined what makes a click reaction as one that 
is wide in scope and easy to perform, uses only readily available reagents, and is 
insensitive to oxygen and water. In fact, in several instances water is the ideal 
reaction solvent, providing the best yields and highest rates. Reaction work-up and 
purification uses benign solvents and avoids chromatography58. Of the reactions 
comprising the click universe, the “perfect” example is the Huisgen 1,3-dipolar 
cycloaddition of alkynes to azides to form 1,4-disubsituted-1,2,3-triazoles . The 
copper(I)-catalyzed reaction is mild and very efficient, requiring no protecting groups, 
and requiring no purification in many cases59. The azide and alkyne functional groups 
are largely inert towards biological molecules and aqueous environments, which 
allows the use of the Huisgen 1,3-dipolar cycloaddition in target guided synthesis and 
activity-based protein profiling60. The triazole has similarities to the ubiquitous amide 
moiety found in nature, but unlike amides, is not susceptible to cleavage. 
Additionally, triazoles are nearly impossible to oxidize or reduce. 
In this work our aim was to immobilize glycans for testing of anti-carbohydrate IgE. 
Our strategy based on the formation of a carbohydrate derived azide as a linker for 
the building of a 1,2,3-triazole. For this purpose we have chosen 6-azido-6-deoxy-D-
glucose 30 as a candidate, which can be oxidized to the corresponding carboxylic 
acid which may be transformed into an ester or lactone.  
 
 
Figure23 Oxidation of 6-azido-6-deoxy-D-glucose 
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In the second step the alkyne derivative can bind to a microtitre plate which carries 
amino groups on the surface, in our work we have used ethyl propiolate as alkyne 
source which can bind to the microtitre plate through the formation of amide bond as 
shown in Figure 24.   
 
 
 
 
The lactone formed in the first step can react in excess with the glycopeptide of 
interest as shown in Figure 25. 
 
 
 
 
 
Finally the formed glycopeptide-azidogluconolactone can bind in a click reaction to 
the microtitre plate through triazole formation as shown in Figure 26. 
 
Figure 24 The binding of the alkyne ester to the 
micro titre plate 
Figure 25 Reaction of the azidogluconolactone with a glycopeptide of interest 
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6-Azido-6-deoxy-D-glucose 30 was coupled with ethyl propiolate. The reaction 
between the azide derivatives and ethyl propiolate was done in the presence of 
copper (II) sulfate and sodium ascorbate in a ratio of 1:5. The total reaction was 
carried out in a mixture of 2:1 of water to tert-butyl alcohol at room temperature for 8h 
to afford the 1,4-disubstituted triazole product in a crystalline form.  
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Figure 26 Formation of triazole on the microtitre plate 
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5.4 Pharmaceutical and Technical applications 
 
The carbohydrate derived azides synthesized within this work can be used in 
different applications as follow;   
5.4.1 Azido-cellobiose derivatives  
1. Precursors for the formation of aminopolysaccharides with unique 
structures. These aminopolysaccharides can play an important role as 
pharmaceutical excipients  
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Aminopolysaccharides with amino groups on different glucose moieties 
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• In the case of 6-azido-6-deoxy-D-cellobiose, the resulting polymer carries the 
azido group on the reducing glucose moiety. 
• While in the case of 6’-azido-6’-deoxy-D-cellobiose the azido group is located 
on the non-reducing glucose unit. 
2. 6'-Azido-6'-deoxy-cellobionolactone 38 can act as a starting material for the 
preparation of new hydrogels shown in Figure 27. 
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The polymerization reaction leads to a biodegradable hydrogel with unique structure, 
such biodegradable hydrogels can find wide applications in the improvement of 
existing dosage forms and the development of new and better drug delivery systems. 
Figure 27 shows the polymerization of 6‘-azido-6’-deoxy-cellobionolactone to a 
hydrogel 
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5.4.2  Azido glucose derivatives 
3-Azido-3-deoxy-D-glucose 
3-Azido-3-deoxy-D-glucose can be transformed under catalysis by hexokinase and 
ATP into 3-azido-3-deoxy-D-glucose-6-phosphate, the latter can be incorporated as a 
glucose analog into an UDP sugar molecule to give the UDP-3-azido-3-deoxy-
glucose, which could be used as  a substrate for diverse synthase enzymes for 
example sucrose synthase and cellulose synthase . In the first example a synthesis 
of new sweetener is possible while in the second case the incorporation of 3-amino-
3-deoxy-D-glucose in a polysaccharide can be considered.  
U
TP
 
 
 
Another application for 3-azido-3-deoxy-D-glucose could drive from its ability to be 
oxidized to the corresponding lactone which is an appropriate  precursor for the 
polymerization of a new polyamide backbone . 
 
 
 
 
Figure 28: Incorporation of 3-azido-3-deoxy-D-glucose in UDP 
Figure 29 Hypothetical polyamide backbone from 3-azido-3-deoxy-D-glucose 
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5.4.3  Applications of 1,2,3-Triazoles 
 
It is reported that 1,2,3-triazoles show biological activities and there are numerous 
examples in the literature including anti-HIV activity, antimicrobial activity against 
gram positive bacteria and selective β3 adrenergic receptor agonism61. Moreover 
1,2,3-triazoles have found broad use in agrochemicals and industrial applications 
such as dyes and corrosion inhibitors, photostabilizers and photographic materials62. 
 
1,2,3- Triazoles derived from azido sugars offer other advantages owing to the 
presence of the aldehyde function of glucose that can be oxidized to carboxylic acids. 
  
 
 
The later can be transformed into esters or lactones and can bind to glycopeptides 
through an amide bond. This property offers 1,2,3-triazole the ability to act as a 
linking arm and can be widely used in diagnostic purposes. 
The Figure below show the formation of a 1,2,3-triazole from ethyl propiolate as 
alkyne and 6-azido-6-deoxy-D-glucose as azido sugar.  
  
 
 
 
Both the propiolate and sugar moieties contain additional functional groups suitable 
for coupling to conventional carriers and biological ligands prior to triazole formation. 
Figure 30  bifunctionalized triazole from ethylpropiolate and 6-azido-6-deoxy-D-glucose 
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In a similar way, 6-azido-6-deoxy-cellobiose 20 could potentially be coupled with the 
same alkyne to afford the 1,4- disubstituted triazole product as shown in Figure 31. 
 
 
 
 
Beside the application of these 2 triazoles as linking arms for diagnostic purposes, 
they could also be tested for biological activity, for example if they show any cytotoxic 
properties.   
 
Figure 31 Bifunctionalized triazole from ethylpropiolate and 6-azido-6-deoxy-D-cellobiose 
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6. Outlook 
 
The organic-chemical and enzyme-catalyzed syntheses described in this work are a 
part of a wide plan aims to postulate innovative synthetic strategies for different 
structures including aminopolysaccharides and hydrogels. Such biomimetic artificial 
materials can solve many problems accompanied with the naturally occurring 
polymers such as the presence of copolymers of biogenic origin. Furthermore such 
materials can be used in pharmaceutical, medical and technical applications.  
Concerning azido derivatives of cellobiose, this work can be enriched if other 
derivatives can be synthesized; e.g. the introduction of azido group in the 2nd and 3rd 
positions of both reducing and non-reducing glucose moieties of cellobiose.   
As to the enzymatic synthesis using cellobiose phosphorylase, there is a need for 
cooperation with enzymologists to develop genetically modified mutants of CBP that 
catalyzes only the reversal synthetic reactions rather than the forward one. In this 
manner, the large scale synthesis of new sugars will be possible. Our observation 
that CBP can also catalyze the synthesis of a trisaccharide is considered to be of 
great importance and needs more verification. 
Concerning the triazole synthesis and their applications, screening tests may be 
needed to verify any biological activity and in case of positive results the formation of 
these stable triazoles can be expanded, so that new library of different triazoles 
prepared from all azido sugars gained in this work can be achieved. 
For the application of the coupled product in diagnostics some efforts are needed in 
order to quantify the binding glycopeptide of interest on the microtitre plate. This work 
is under development. 
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7.  Experimental Section 
7.1.  Materials  
 
• Cellobiose (compound 1), 1,2:5,6-Di-O-isopropylidene-α-D-glucofuranose 
(compound 31), were purchased from GLYCON Biochemicals, Luckenwalde, 
Germany. 
 
• Acetic anhydride, acetone, acetonitrile, activated charcoal (untreated, 
granular, 4-8 mesh), allyl alcohol, benzaldehyde, benzene, benzoyl chloride, 
calcium hydride, chloroform, α-D-Cellobiose octaacetate 98%, Diazald®, 
dichloromethane, diisopropyl ether, dimethyl sulphoxide, Drierite® 6 mesh with 
and without indicator, ethylacetate, glacial acetic acid, ethanol, hexane, 
hydrobromic acid solution 33% in acetic acid, isopropanol, magnesium sulfate, 
magnesium turnings, mercuric cyanide, methanesulfonyl chloride, methanol, 
molecular sieves 4 Å pellets, N,N-dimethylformamide(DMF), silver fluoride, 
sodium azide, sodium bicarbonate, sodium borohydride, sodium carbonate, 
sodium chloride, sodium hydrogen sulfate, palladium(II)chloride, propanol, 
pyridine, zinc chloride, toluene, were purchased from Sigma-Aldrich Chemie 
GmbH, Steinheim, Germany.  
 
Dried pyridine: commercially available pyridine (Sigma-Aldrich) was refluxed 
over calcium hydride for 4h, and then distilled from calcium hydride with 
exclusion of moisture. 
  
Dried chloroform: commercially available chloroform was refluxed over P2O5 
for 4h and then distilled.  
 
Dried dichloromethane: commercially available dichloromethane was refluxed 
over calcium hydride for 4h, and then distilled from calcium hydride with 
exclusion of moisture. 
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Dried acetonitrile: commercially available acetonitrile was refluxed over 
calcium hydride for 4h, then distilled from calcium hydride with exclusion of 
moisture. 
 
Dried methanol: 500 ml commercial methanol (Sigma-Aldrich) reacted with 
magnesium turnings (~1 g), refluxed for 4h, and then distilled from the Mg-
methoxide formed with exclusion of moisture (Drierite drying tube). 
 
Dried allyl alcohol: 500 ml commercially available allyl alcohol (Aldrich) was 
dried over ~80 g Drierite for 48h at room temperature. 
 
Dried dimethylformamide: 500 ml commercially available dimethylformamide 
(Aldrich) was dried over ~80 g Drierite for 48h at room temperature. 
 
Dried dimethyl sulphoxide: 500 ml commercially available dimethyl sulphoxide 
was dried over preheated molecular sieves® 4Å for 48h. 
 
Dowex mixed bed (AG 501-X8 Resin), and Dowex 50-H+ (Ag 50W-X8 
Resin): Bio-Rad Laboratories, Richmond, California  
 
Cellobiose phosphorylase: from Clostridium thermocellum was extracted in 
our laboratories as described under methods. 
Cellobiose dehydrogenase: was obtained from Dr.Roland Ludwig, Department 
of Food Science and Technology, BOKU, University of Applied Life Sciences, 
Muthgasse 18, 1190 Wien. 
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7.2 Methods 
 
- Preparative Column Chromatography was performed on columns of Silica gel 
60 (0,040-0,063 mm), supplied by Merck KgaA, Darmstadt, Germany. 
- Thin layer chromatography (TLC): Thin layer chromatograms were developed 
in glass jars on glass-backed, standard 5×10 cm plates of silica gel 60 F254 
supplied by Merck KgaA, Darmstadt, Germany. For visualization, plates were 
sprayed, using glass vaporizer bottles equipped with a rubber balloon, with a 
modified anisaldehyde-sulfuric acid spray reagent (anisaldehyde, 0.5 ml; 
ethanol, 9 ml; conc. H2SO4, 0.5 ml; glacial acetic acid, 0.1 ml)63. To protect the 
operator from the harmful mist, it is advantageous to use a spraying cabinet in 
a well-ventilated hood. After spraying, plates were heated for ∼3 min on a 
hotplate equipped with an aluminium block at a setting of ∼150°C (not 
calibrated). Colorations are best observed immediately, as differences in color 
shades tend to become less prominent with time. 
For graphic TLC representation, sprayed plates were scanned with the aid of a 
canon scanner, and the digital files printed directly or edited using the program 
Adobe Photoshop 5.0. Edited chromatograms have been prepared to 
emphasize the differences in colorations rather than to indicate quality of the 
chromatographic separations or purity of the materials used. 
 
- Preparative layer chromatography (PLC): 20×20 cm PSC-plates of silica gel 
60 F254, 2 mm, supplied by Merck KgaA, Darmstadt, Germany. 
- Melting points were determined on a Kofler hot stage and are uncorrected. 
- Optical rotations were performed with the aid of a “Perkin Elmer 341” 
polarimeter. 
- Elemental analyses were performed with a “2400 CHN Elemental Analyzer” 
from Perkin Elmer. 
- Infra-red-spectra were performed with a “Perkin Elmer 1600 FT-IR” 
spectrometer on silica-plates. 
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- NMR-spectra were performed with NMR-spectrometers from Bruker, an 
“Avance DPX 250“ at 250.13 and 62.90 MHz, an „Avance DRX 400“ at 400.13 
and 100.61 MHz, and an „Avance DRX 600“ at 600.13 and 150.92 MHz. The 
calibration was performed on internal standards of solvents (1H-NMR: CHCl3 in 
CDCl3 7.24 ppm, H2O in D2O 4.79 ppm; 13C-NMR: CDCl3 77.00 ppm). The 
chemical shift (δ) is given in ppm, the coupling constant J is given in Hertz 
(Hz). 
 
Synthesis of diazomethane; 
 
5 g of Diazald were suspended in ether, then dropped 
through dropping funnel into the KOH solution, followed by 
distillation at 65°C .The formed diazomethane was collected 
in a cooled round bottom falsk, the solution is yellow 
Brown. The obtained diazomethane was applied directly. 
 
 
 
 
Extraction of Cellobiose phosphorylase; 
 
a) Fermentation and harvest of the anaerobic bacterium, Clostridium 
thremocellum, as a source of Cellobiose phosphorylase - Clostridium 
thremocellum NCIMB 10682 was used as CBPase producer and was cultured 
in a medium containing the following (g/liter): Cellobiose, 2.0g; Yeast extract, 
2.0g; (NH4) SO4, 1.30g; KH2PO4, 1.50g; K2HPO4.3H20, 2.90g; MgCl.6H20, 
1.0g; CaCl2, 0.15g; Resazurin (0.2%), 1.0ml; FeSO4.7H2O (5%), 25.0µl; 
distilled water, 1l. The microorganism was incubated anerobically at 60°C. 
After incubation cells were harvested by centrifugation.  
b) Sonication of the bacteria – Sonication was performed by ultrasonic probe five 
times for 20 sec on ice to break down the cells. Cell debris was removed by 
 
Fig. 32 Distillation 
apparatus for diazomethane 
 
Sigma-Aldrich catalogue 2007 
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centrifugation. The cleared lysate (supernatant) was concentrated with 
VIVASPIN 20 by centrifugation to a volume of 10ml. 
c) Column chromatographic enrichment and purification of the enzyme CBPase 
– The native CBPase was purified using a column chromatography procedure 
(DEAE) as reported by Alexander64.  
d) Thin layer chromatography (TLC): To ensure the activity of the enzyme CBP,  
the purified extract was incubated with cellobiose in the presence of 
phosphate buffer pH 7.0 at 37°C. In order to detect the phosphorolysis of D-
cellobiose a TLC-Assay was performed subsequently. 
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7.3 Overview of carbohydrate syntheses. Schemes of syntheses 
 
1. Synthesis of 6'-azido-6'-deoxy-cellobiose Scheme 1 see page 44 
2. Synthesis of 6-azido-6-deoxy-cellobiose Scheme 2 see page 46 
3. Synthesis of 6-azido-6-deoxy-D-glucose Scheme 3 see page 48 
4. Synthesis of 3-azido-3-deoxy-D-glucose Scheme 4 see page 50 
5. Synthesis of β-D-allose    Scheme 5 see page 51 
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7.4 Chemical syntheses description 
 
1,2,3,6-Tetra-O-acetyl-4-O-(2’,3’,4’,6’-tetra-O-acetyl-β-D-glucopyranosyl)-D-
glucopyranoside  2 
 
 
O
O
HO
HO
OH
OH OH
OH
OHHO
O
AcOAc / Pyridin O
O
AcO
AcO
OAc
OAc OAc
OAc
AcO
O
OAc C2 8H38O1 9
Mol. Wt.: 678,59
C, 49,56; H, 5,64; O, 44,80
1 2
 
 
Preparation: 
 
In a 500 ml round bottom flask (50g, 0.145 mole) cellobiose 1 was suspended in (150 
ml) dry pyridine, 150 ml (1.575 mole) acetic anhydride was dropped from a dropping 
funnel sealed with a drying tube (Drierite), into the suspension. The reaction 
mixture was cooled in ice-water bath, stirred with a magnetic stirrer and allowed to 
come to room temperature. After stirring over night, the content of the flask was 
poured onto ice and stirred further for 30 min. The formed product was filtered under 
vacuum and washed several times with distilled water. The product was stored under 
vacuum. The mother liquor was evaporated and treated again similar to the previous 
steps. The 2 products were gathered and dried in a dessicator over Drierite and 
gave a total yield 84.38 g 0.124mole (85%) of 2. 
 
Characterisation: 
 
TLC (EE:T 3:2): RF  educt 1 0.00 
    product 2 0.68 
 
2: Optical rotation: [ ]20Dα = - 12.1° (CHCl3; 0.5 g/100 ml) 
2: m.p.: 198-199°C 
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2’,3’,4’,6’-Tetra-O-acetyl-β-D-glucopyranosyl-(1→4)-2,3,6-tri-O-acetyl-1-bromo-
1-deoxy-α-D-glucopyranoside  3 
 
 
O
O
AcO
AcO
OAc
OAc OAc
OAc
AcO
O
OAc
HBr / HOAc O
O
AcO
AcO
OAc
OAc OAc
AcO
AcO
O
Br
C26 H35BrO17
Mol. Wt.: 699,45
C, 44,65; H, 5,04; Br, 11,42; O, 38,89
32
 
 
 
Preparation: 65 
 
50 g of Cellobiose octaacetate 2 (0.075mole) was dissolved in 120 ml dry chloroform 
and magnetically stirred in ice-water bath. 80 ml of hydrogen bromide in acetic acid 
(30 wt %) diluted with 20 ml dry chloroform was dropped over 30min from a dropping 
funnel sealed with a drying tube (Drierite). The reaction mixture was stirred for 
another 4h and stored at 4°C over night. In a separatory funnel the reaction mixture 
was poured onto ice-water, extracted with chloroform. The chloroform layer washed 4 
times with ice-cold water, once with NaHCO3 and finally with NaHSO4. The 
chloroform layer was then dried over anhydrous Mg2SO4, filtered and evaporated 
under vacuum to give 52.9 g (0.075 mole) white crystals of product 3. The product 
was recrystallized from diisopropylether and dry tetrahydrofuran to give 48.67 g 
(0.069 mole) of the pure product with total yield of 92 %. After recrystallization the 
product was stable over a long time.  
 
Characterisation: 
 
TLC (EE: T / 1:1): RF  educt 2 0.65 
     product 3 0.72 
 
3: m.p.: 177-179°C 
 
 
92 
 
2’,3’,4’,6’-Tetra-O-acetyl-β-D-glucopyranosyl-(1→4)-allyl 2,3,6-tri-O-acetyl-β-D-
glucopyranoside  4 
 
 
O
O
AcO
AcO
OAc
OAc OAc
AcO
AcO
O
Br
HG(CN)2 / AllOH
O
O
AcO
AcO
OAc
OAc OAc
AcO
AcO
O
O
4
C29H40 O18
Mol. Wt.: 676,62
C, 51,48; H, 5,96; O, 42,56
3
 
 
 
Preparation: 66 
 
In a 500 ml round bottom flask, hepta-O-acetyl cellobiosyl bromide (45.0 g 0.064 
mole) 3 was dissolved in 100 ml dry CH2Cl2, 10 g Drierite was added. To the 
magnetically stirred solution 12 g of mercury (II) cyanide was added and the flask 
sealed with a drying tube (Drierite). After 36 hours stirring at room temperature, thin 
layer chromatography (EE: T / 3:2) indicated complete consumption of 3. The 
reaction mixture was then diluted with 50 ml of CH2Cl2 stirred for further 30 min., the 
reaction mixture was then filtered over Celite®, and the filtrate was evaporated under 
vacuum to give 42 g (0.062 mole) of 4. The product was recrystallized from 
isopropanol to give a yield of 80% (35.0 g) of compound 4 .     
 
 
Characterisation: 
 
TLC (EE:T/ 3:2):    RF educt 3 0.58  
product 4 0.62 
 
 
4: Optical rotation: [ ]20Dα = - 39.43° (CHCl3; 0.05 g/100 ml) 
4: m.p.: 190-191°C 
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1H-NMR (CDCl3, 400 MHz) δ [ppm]: 
 
5.33-5.77 (m: 1H; allyl –CH2-CH=CH2); 5.28-5.19 (m; 2H; allyl -=CH2); 5.17 (dd; 1H; 
H3’; J2’,3’ =9.37 Hz); 5.13 (dd; 1H; H3; J3,4=9.37 Hz); 5.04 (dd; 1H; H4; J4,5=9.54 Hz); 
4.94-4.89 (m; 2H; H2’, H2); 4.53-4.49 (m; 3H; H1’, H1, H6a; J5,6a=7.89 Hz); 4.36 (dd; 
1H; H6a’; J5’.6a’ =4.44 Hz; J6a’,6b’ =12.42 Hz); 4.12-4.02 (m; 3H; allyl –O-CH2-, H6b’, 
H6b); 3.78 (dd; 1H; H4’; J3’,4’ =9.37 Hz; J4’,5’ =9.62); 3.65 (m; 1H; H5); 3.57 (m; 1H; 
H5’); 2.20-1.95 (7 s; 21H; -COCH3). 
 
 
13C-NMR (CDCl3, 100 MHz) δ [ppm]: 
 
170.86, 170.68, 170.59, 170.19, 169.97, 169.68, 169. 41 (7C, -COCH3); 133.72 (allyl 
–CH=CH2); 118.02 (allyl-=CH2); 101.16 (C1); 99.77 (C1’); 73.33 (C3’); 73.07 (C3); 
72.93 (C5’); 72.36 (C5); 72.02 (C2); 71.95 (C2’); 70.41 (allyl –O-CH2-); 62.26 (C6); 
61.96 (C6’); 21.23-20.91 (7C, -COCH3). 
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β-D-Glucopyranosyl-(1→4)-allyl β-D-glucopyranoside 5 
 
 
O
O
HO
HO
OH
OH OH
OH
HO
O
ONaOMe/MeOHO
O
AcO
AcO
OAc
OAc OAc
AcO
AcO
O
O C15H2 6O11
Mol. Wt.: 382,36
C, 47,12; H, 6,85; O, 46,03
54
 
 
 
Preparation: 
 
In a 250 ml round bottom flask 25 g (0.037 mole) of 4 was dissolved in 80 ml dry 
methanol. To the magnetically stirred solution 12.0 ml of freshly prepared NaOCH3 
(300 mg Na / 100ml CH3OH) was added. After 2 hours at room temperature TLC 
(EE: T / 3:2) indicated the consumption of the educt. The solution was neutralized 
with Dowex® 50-H+, filtered and evaporated to give 14.5 g (~100%) of 5. 
 
 
Characterisation: 
 
TLC (EE: T / 3:2): RF   educt 4 0.69 
      product 5 0.00 
 
TLC (propanol: H2O / 17:3): RF  educt  4 0.83 
      Product 5 0.51 
5: m.p.: 150-151°C 
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4’,6’-O-Benzylidene-β-D-glucopyranosyl-(1→4)-allyl β-D-glucopyranoside  6 
 
 
O
O
HO
HO
OH
OH OH
OH
HO
O
O O
OHO
OH OH
OH
HO
O
OO
OPh
PhCHO / ZnCl2 C22 H30O1 1
Mol. Wt.: 470,47
C, 56,16; H, 6,43; O, 37,41
65
 
 
 
Preparation: 67 
 
In a round bottom flask, 50 ml of freshly distilled benzaldehyde and 7.3 g of 
preheated zinc chloride were added to (8.0 g, 0.021mole) of compound 5. The flask 
was tightly stoppered and shaken on a mechanical shaker at 200 rpm for 36 hours. 
After TLC indicated the complete consumption of the educt, the product was 
extracted as follows. 
• In a 600 ml beaker, a saturated solution of NaHCO3 (200 ml) and hexane  
 (100 ml) were added 
• The solution was vigorously stirred with a mechanical stirrer 
• The reaction mixture was pipetted into the stirred solution 
• The hexane phase was discarded after 20 min. stirring and a fresh 100 ml of 
hexane was added; this step was repeated 4 times. 
• The precipitated product was then filtered under vacuum and washed twice 
with hexane, then several times with distilled water. 
• Finally the product was stored in a desiccator and dried under vacuum to give 
9.48 g (0.020 mole) of 6 with a yield of 96%. 
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Characterisation: 
 
TLC (ethyl acetate/ isopropanol 10:1): RF educt 5 0.00 
       product 6 0.39 
 
6: Optical rotation: [ ]20Dα = - 23.70° (CHCl3; 0.05 g/100 ml) 
6: m.p.: 192-193°C 
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2’,3’-Di-O-acetyl-4’,6’-O-benzylidene-β-D-glucopyranosyl-(1→4)-allyl 2,3,6-tri-
O-acetyl-β-D-glucopyranoside  7 
 
 
 
 
Preparation: 
 
Compound 6 (9.0 g, 0.019 mole) was suspended in 30 ml of dry pyridine, after the 
addition of 30 ml 0.315 mole of acetic anhydride the reaction mixture was stirred in 
an ice-water bath overnight. After TLC had indicated the complete consumption of 
the educt, the whole content of the flask was poured onto ice water. The formed 
product was then filtered under vacuum and washed several times with distilled 
water. The product was dried in a desiccator and was recrystallized from isopropanol 
to afford 12.3 g (0.018 mole) of 7 with a yield of 95%.      
 
 
Characterisation: 
 
TLC (ethyl acetate:isopropanol / 10:1): RF educt 6 0.40 
       product 7 0.75 
 
 
7: Optical rotation: [ ]20Dα = - 50.03° (CHCl3; 0.5 g/100 ml) 
 
7:m.p.: 228-230°C 
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IR: ν [cm-1] 2876 (w), 1300 (s) =CH2 valency and deformation oscillation, 1372 
(O)COCH3 valency oscillation. 
 
1H-NMR (CDCl3, 400 MHz) δ [ppm]: 
 
7.40-7.38 (m; 2H; aromatic protons); 7.34-7.32 (m; 3H; aromatic protons); 5.76-5.87 
(m: 1H; allyl –CH2-CH=CH2); 5.45 (s; 1H; -CHPh); 5.23 (dd; 2H; allyl-=CH2, H3’; 
J3’,4’=9.45 Hz); 5.15 (dd; 2H; allyl-=CH2, H3; J3,4=9.45 Hz); 4.95 (dd; 1H; H2’; 
J2’,3’=8.29 Hz); 4.89 (dd; 1H; H2; J2,3=8.29 Hz); 4.57 (d; 1H; H1’; J1’,2’=7.79 Hz); 4.49 
(d; 1H; H1; J1,2=8.12 Hz); 4.47 (dd; 1H; H6a; J6a,6b=10.12 Hz); 4.33 (dd; 1H; H6a’; 
J5’,6a’=4.98 Hz; J6a’,6b’=9.45 Hz); 4.30-4.02 (m; 2H; allyl–O-CH2-); 4.08-4.02 (m; 2H; 
allyl –O-CH2-, H6b); 3.78 (dd; 1H; H4; J4,5=8.46 Hz); 3.70 (dd; 1H; H6b’; J5’,6b’=10.12 
Hz); 3.78 (dd; 1H; H4’; J4’,5’=9.62 Hz); 3.55 (ddd; 1H; H5); 3.45 (ddd; 1H; H5’); 2.10 
(s; 3H; -COCH3); 2.03 (s; 3H; -COCH3); 2.01 (s; 3H; -COCH3); 1.99 (s; 6H; -COCH3). 
 
13C-NMR (CDCl3, 100 MHz) δ [ppm]: 
 
171.75, 171.53, 171.01, 170.96, 170.79 (5C, -COCH3); 137.99 (1 quaternary 
aromatic carbon atom); 134.75 (allyl –CH=CH2); 130.63, 130.40, 129.68, (5 tertiary 
aromatic carbon atoms); 127.51 (–CHPh); 119.04 (allyl -=CH2); 102.96 (C1’); 100.67 
(C1), 77.87 (C4’); 77.21 (C4); 74.86 (C3); 74.00 (C5); 73.93 (C2); 73.34 (C3’); 73.16 
(C2’); 73.12 (C6); 70.70 (C6’); 67.76 (C5’); 63.31 (allyl –O-CH2-); 22.38-21.91 (5C; -
COCH3). 
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2’,3’-Di-O-acetyl-β-D-glucopyranosyl-(1→4)-allyl 2,3,6-tri-O-acetyl-β-D-
glucopyranoside  8 
 
 
 
 
Preparation: 
 
In a 250 ml round bottomed flask, compound 7 (12.0 g 0.017 mole) was suspended 
in 100 ml of 60% acetic acid solution and then refluxed at 100°C for 2 hours. After 
TLC (Toluene/ethyl acetate 3:2) had indicated the complete consumption of the 
educt, the reaction mixture was left to cool to room temperature, subsequently the 
solution was neutralized with sodium bicarbonate and extracted with chloroform. The 
chloroform phase was dried over anhydrous Mg2SO4, filtered and evaporated under 
vacuum to give 8.8 g (0.015 mole) white crystals of 8, which were stored at 4°C. 
 
 
Characterisation: 
 
TLC (T: EE / 3:2): RF educt 7 0.72 
    product 8 0.03 
 
8: m.p.: 181°-183°C 
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2’,3’-Di-O-acetyl-6’-O-methylsulfonyl-β-D-glucopyranosyl-(1→4)-allyl 2,3,6-tri-
O-acetyl-β-D-glucopyranoside  9 
 
 
O
O
AcO
OAc
OAc
OAc
AcO
O
O
HO
MsO
MsCl / Pyridin
- 30°c
9
O
O
AcO
OAc
OAc
OAc
AcO
O
O
HO
HO
8
C26H38O18S
Mol. Wt.: 670,63
C, 46.56; H, 5.71; O, 42.94; S, 4.78
 
 
Preparation: 
 
In a 100 ml round bottomed flask, 5.75 g (9.7 mmole) of compound 8 was dissolved 
in 50 ml of dry pyridine. To the magnetically stirred solution 0.8 ml (10.67 mmole) of 
methanesulfonyl chloride diluted with 10 ml of dry CH2Cl2 was dropped through a 
dropping funnel over 4h. The reaction temperature was kept constant at -30°C using 
dry ice. After TLC had indicated the complete consumption of the starting material 
the reaction mixture was poured onto ice, stirred for a further 30 min, then extracted 
with chloroform. The chloroform phase was washed once with NaHSO4 then with 
NaHCO3 solutions, dried over anhydrous Mg2SO4, filtered and finally evaporated 
under vacuum to give 4.85 g (7.23 mmole) of 9 with a yield of (75%) which is 
recrystallized from 96% ethanol. 
 
 
Characterisation: 
 
TLC (EE: T / 3:2): RF educt 8 0.10 
    product 9 0.41 
9: m.p.: 186°-188°C 
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2’,3’,4’-Tri-O-acetyl-6’-O- methylsulfonyl-β-D-glucopyranosyl-(1→4)-allyl 2,3,6-
tri-O-acetyl-β-D-glucopyranoside  10 
 
 
 
 
Preparation: 
 
To product 9 (4.85 g 7.23 mmole), 30 ml of dry pyridine and 30 ml of acetic anhydride 
were added. The reaction mixture was stirred in an ice-water bath over night. After 
TLC has indicated the compelete consumption of the educt, the reaction mixture 
poured onto ice, stirred , filtered under vacuum and washed several times with 
distilled water. The product was then recrystallized from 96% ethanol to give 4.80 g 
(6.7 mmole) of  pure crystals of 10 with a yield of 92%. 
 
 
Characterisation: 
 
TLC (EE: T / 3:2): RF educt 9 0.41 
    product 10 0.65 
 
10: m.p.: 204°- 206°C 
 
102 
 
2’,3’,4’-Tri-O-acetyl-6’-azido-6’-deoxy-β-D-glucopyranosyl-(1→4)-allyl 2,3,6-tri-
O-acetyl-β-D-glucopyranoside 11 
 
 
 
 
Preparation: 
 
In a round bottomed flask 1.0 g (1.4 mmole) of 10 was dissolved in 25 ml dried DMF. 
To this solution 1.12 g NaN3 was added and refluxed in an oil bath at 120°C for 2h. 
After TLC had indicated the consumption of the starting material, the reaction mixture 
was cooled and evaporated under vacuum. The residue was dissolved in chloroform 
and washed several times with distilled water. The chloroform phase was then dried 
over anhydrous Mg2SO4, filtered and evaporated under vacuum to afford 750 mg 
(1.14 mmole) of 11 in 81% yield. 
 
 
Characterization: 
 
TLC (EE: T / 3:2): RF educt 10 0.49 
    product 11 0.67 
11: m.p.: 136°-137°C 
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2’,3’,4’-Tri-O-acetyl-6’-azido-6’-deoxy-β-D-glucopyranosyl-(1→4)-2,3,6-tri-O-
acetyl-β-D-glucopyranoside 12 
 
 
 
 
Preparation:68 
 
In a round bottomed flask 750 mg (1.14 mmole) of compound 11, was dissolved in 60 
ml of 88% acetic acid. To this solution, 350 mg of sodium acetate and 350 mg of 
PdCl2 were added. The reaction mixture was stirred for 48 hours, after that TLC had 
shown the complete consumption of 11.  The reaction mixture was neutralized with 
saturated solution of NaHCO3, 50 ml chloroform added and the mixture filtered over 
Celite®, chloroform phase separated in a separatory funnel, dried over anhydrous 
MgSO4, filtered and evaporated under vacuum to afford 680 mg (1.1 mmole) of 12 
with a yield of 96%. Column chromatography (EE: T/ 3:2) afforded 570 mg (0.92 
mmole) pure crystals of 12 (80% total yield). 
 
 
Characterization: 
 
TLC (EE: T / 3:2): RF educt 11 0.65 
    product 12 0.24 
12: m.p.: 170°-172°C 
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6’-Azido-6’-deoxy-β-D-glucopyranosyl-(1→4)-β-D-glucopyranoside  13 
 
 
 
 
Preparation: 
 
Compound 12 (500 mg 0.81 mmole) was suspended in 10 ml of dry methanol,   a 
catalytic amount (0.2 ml) of freshly prepared sodium methoxide (230 mg Na /100ml 
methanol) was added to the reaction mixture. After TLC indicated the complete 
conversion of 12 to 13, the reaction mixture was neutralized by Dowex®-H+, filtered 
and evaporated under vacuum to give 295 mg (0.80 mmole) of 13.  
 
 
Characterization: 
 
TLC (EE: T / 3:2): RF   educt 12 0.43 
      product 13 0.0 
 
TLC (Bu: Pr: Et: H2O/2:3:3:2): RF   educt 12 0.75 
      product 13 0.50 
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4’,6’-O-Benzylidene-β-D-glucopyranosyl-(1→4)-allyl 6-O-methylsulfonyl-β-D-
glucopyranoside  14 
 
 
 
 
Preparation: 
 
In a 250 ml round bottom flask 8.0 g (0.017 mole) of compound 6 was dissolved in 75 
ml dry pyridine. To the magnetically stirred solution, 1.5 ml (0.0187 mole) of 
methanesulfonyl chloride diluted with 10 ml of dry CH2Cl2 was dropped through  
 a dropping funnel over 4h. The reaction was cooled at -30°C using dry ice. After TLC 
has indicated the complete consumption of the starting material the reaction mixture 
was poured onto ice, stirred for a further 30 min, then extracted with chloroform. The 
chloroform phase was washed once with NaHSO4 then with NaHCO3, dried over 
anhydrous Mg2SO4, filtered and finally evaporated under vacuum to give 8.50 g 
(0.015 mole) of the syrupy product of 9 ( yield of 91%) which is directly applied for the 
next step without any purification. 
 
 
Characterisation: 
 
TLC (EE: ISO / 10:1):    RF educt 6 0.36 
       product 14 0.51 
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2’,3’-Di-O-acetyl-4’,6’-O-benzylidene-β-D-glucopyranosyl-(1→4)-allyl 2,3-di-O-
acetyl-6-O-methylsulfonyl-β-D-glucopyranoside  15 
 
 
 
 
 
Preparation: 
 
Compound 14 (8.5 g 0.015 mole) was suspended in 70 ml of dry pyridine, and acetic 
anhydride (70 ml) was added to the magnetically stirred solution under cooling in an 
ice-water bath. The vessel was sealed with a drying tube (Drierite), allowed to 
come to room temperature, and stirring continued over night. TLC indicated the end 
of the reaction. The content of the flask was then poured onto ice water and 
extracted with chloroform and the chloroform phase washed with saturated solutions 
of sodium hydrogen sulfate and sodium hydrogen carbonate, respectively. The 
organic phase was dried over anhydrous magnesium sulfate, filtered and evaporated 
under vacuum to give 10.50 g (0.015 mole) of compound 15 in 98% yield.  
 
 
Characterisation: 
 
TLC (EE:T / 3:2): RF   educt 14 0.28 
      product 15 0.76 
 
82: m.p.: 192-194°C 
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IR: ν [cm-1] 2876 (w), 1300 (s) =CH2 valency and deformation oscillation, 1372 
(O)COCH3 valency oscillation, 1740(s) -C=O valency oscillation, 1360 (s), 1178 (s) –
O-SO2 oscillation. 
 
1H-NMR (CDCl3, 400 MHz) δ [ppm]: 
 
7.41-7.38 (m; 2H; aromatic protons); 7.35-7.32 (m; 3H; aromatic protons); 5.84-5.77 
(m: 1H; allyl –CH2-CH=CH2); 5.45 (s; 1H; -CHPh); 5.25 (dd;1H; H3’; J3’,4’=9.71 Hz); 
5.25-5.19 (dd; 2H; allyl-=CH2); 5.19 (m; 2H; allyl-=CH2, H3); 4.93 (dd; 1H; H2’; 
J2’,3’=7.92 Hz); 4.87 (dd; 1H; H2; J2,3=8.01 Hz); 4.66 (d; 1H; H1’; J1’,2’=7.74 Hz), 4.53 
(d; 1H; H1; J1,2=7.91 Hz); 4.53 (dd; 1H; H6a; J5,6a=1.89 Hz); 4.35-4.25 (m; 3H; allyl-
=CH2, H6a’, H6b’); 4.10-4.05 (1H; allyl-=CH2); 3.82 (dd; 1H; H4; J4,5=9.26 Hz); 3.70 
(dd; 1H; H6b; J6a,6b=10.36 Hz); 3.65 (dd; 1H; H4’; J4’,5’=10.63 Hz); 3.58 (m; 1H; H5); 
3.47 (m; 1H; H5’); 3.07 (s; 3H; -OSO2-CH3); 2.08-1.99 (4 s; 12H; ; -COCH3). 
 
13C-NMR (CDCl3, 100 MHz) δ [ppm]: 
 
171.41, 171.02, 170.95, 170.82 (4C, -COCH3); 137.99 (1 quaternary aromatic carbon 
atom); 134.53 (allyl –CH=CH2); 130.63, 129.68, 127.54, (5 tertiary aromatic carbon 
atoms); 119.27 (allyl -=CH2); 103.21 (–CHPh); 103.00 (C1’); 100.79 (C1), 79.38 
(C4’); 77.38 (C4); 77.21 (C3); 74.46 (C2’); 74.06 (C5); 73.93 (C3’); 73.84 (C2); 73.23 
(allyl –O-CH2-); 72.94 (C6’); 67.77 (C6); 67.46 (C5’); 39.401 (1C; -OSO2-CH3); 
22.34-22.05 (4C; -COCH3). 
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2’,3’-Di-O-acetyl-4’,6’-O-benzylidene-β-D-glucopyranosyl-(1→4)-allyl 2,3-di-O-
acetyl-6-azido-6-deoxy-β-D-glucopyranoside  16 
 
 
 
 
 
Preparation: 
 
In a 250 ml round bottom flask 9.0 g(0.013 mole) of compound 15 was dissolved in  
50 ml dry DMF and 9.0 g sodium azide was added to the magnetically stirred 
solution. The reaction mixture was refluxed in an oil bath at 100°C bath temperature 
for 2 h. After TLC (EE:T 3:2) indicated complete consumption of 15 , the solvent was 
evaporated under vacuum to dryness and the solid residue partitioned between 
chloroform and water (50 ml each). The chloroform phase was washed several times 
with water, dried over magnesium sulphate, filtered and evaporated to a crystalline 
mass of 16, in a yield of 98%, (8.45 g). 16 was recrystallized from isopropanol. 
 
Characterisation: 
 
TLC (EE:T/ 3:2):   RF educt 15 0.65 
     product 16 0.82 
 
16: m.p.: 200-202°C 
 
IR: ν [cm-1] ~ 2100 azide accumulated double bond valency oscillation, 2876 (w), 
1300 (s) =CH2 valency and deformation oscillation, 1740(s) -C=O valency oscillation 
1372 (O) COCH3 valency oscillation. 
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1H-NMR (CDCl3, 400 MHz) δ [ppm]: 
 
7.42-7.38 (m; 2H; aromatic protons); 7.35-7.32 (m; 3H; aromatic protons); 5.86-5.79 
(m: 1H; allyl –CH2-CH=CH2); 5.45 (s; 1H; -CHPh); 5.23 (dd;1H; H3’; J3’,4’=9.54 Hz); 
5.25-5.16 (dd; 1H; allyl-=CH2); 5.15 (m; 2H; allyl-=CH2, H3; J3,4=9.24 Hz); 4.91 (dd; 
1H; H2’; J2’,3’=9.54 Hz); 4.89 (dd; 1H; H2; J2,3=9.32 Hz); 4.58 (d; 1H; H1’; J1’,2’=7.80 
Hz), 4.54 (d; 1H; H1; J1,2=7.94 Hz); 4.32 (dd; 1H; H6a’; J5’,6a’=5.20 Hz; J6a’,6b’=10.4 
Hz); 4.30-4.06 (2H; allyl-CH2); 3.76 (dd; 1H; H4; J4,5=9.32 Hz); 3.70 (dd; 1H; H6b’; 
J5’,6b’=10.33 Hz; J6a’,6b’=10 33 Hz); 3.64 (dd; 1H; H4’; J4’,5’=9.61 Hz); 3.48-3.56 (m; 2H; 
H5, H6a); 3.46 (dd; 1H; H5’); 3.38 (dd; 1H; H6b; J6a,6b=13.01 Hz; J5,6b=5.28 Hz); 2.03 
(s; 3H; -COCH3); 2.01 (s; 3H; -COCH3); 2.005 (s; 3H; -COCH3); 2.002 (s; 3H; -
COCH3). 
 
13C-NMR (CDCl3, 100 MHz) δ [ppm]: 
 
171.55, 170.96, 170.93, 170.63 (4C, -COCH3); 137.98 (1 quaternary aromatic carbon 
atom); 134.70 (allyl –CH=CH2); 130.64, 129.68, 127.52, (5 tertiary aromatic carbon 
atoms); 119.09 (allyl -=CH2); 103.00 (–CHPh); 102.85 (C1’); 100.60 (C1), 79.36 
(C4’); 78.69 (C4); 75.28 (C5); 74.47 (C3); 74.06 (C2); 73.24 (C2’); 72.97 (C3); 71.21 
(allyl –O-CH2-); 69.82 (C6’); 67.82 (C5’); 51.47 (C6); 22.35 (1C; -COCH3), 22.12 (1C; 
-COCH3), 22.08 (1C; -COCH3), 22.06 (1C; -COCH3). 
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2’,3’,-Di-O-acetyl-β-D-glucopyranosyl-(1→4)-allyl 2,3-di-O-acetyl-6-azido-6-
deoxy-β-D-glucopyranoside 17 
 
 
 
 
 
Preparation: 
 
In 250 ml round bottomed flask compound 16 (8.45 g 0.013 mole) was suspended in 
100 ml of 60% acetic acid solution and then refluxed at 100°C for 2 hours. After TLC 
(toluene/ethyl acetate 1:1) had indicated the complete consumption of the educt, the 
reaction mixture was left to cool to room temperature; subsequently the solution was 
neutralized with sodium bicarbonate and extracted with chloroform. The chloroform 
phase was dried over anhydrous Mg2SO4, filtered and evaporated under vacuum to 
give 5.90 g (0.010) mole of 17, which was directly applied for the next step without 
further purification. 
 
 
Characterization: 
 
TLC (EE:T / 1:1):   RF educt 16 0.65 
     Product 17 0.15 
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2’,3’,4’,6’-Tetra-O-acetyl-β-D-glucopyranosyl-(1→4)-allyl 2,3-di-O-acetyl-6-
azido-6-deoxy-β-D-glucopyranoside  18 
 
 
 
 
 
Preparation: 
 
In 250 ml round bottomed flask, compound 17 (5.90 g, 0.010 mole) was suspended 
in 100 ml of 60% acetic acid solution and then refluxed at 100°C for 2 h. After TLC 
(toluene/ethyl acetate 1:1) had indicated the complete consumption of the educt, the 
reaction mixture was left to cool to room temperature; subsequently, the solution was 
neutralized with sodium bicarbonate and extracted with chloroform. The chloroform 
phase was dried over anhydrous Mg2SO4, filtered and evaporated under vacuum to 
give 6.30 g (0.009 mole) white crystals of 18, which were recrystallized from 
isopropanol. 
 
 
Characterisation: 
 
TLC (EE:T / 1:1):    RF educt 17 0.29 
      product 18 0.72 
 
18: Optical rotation: [ ]20Dα = - 30.40° (CHCl3; 0.05 g/100 ml) 
 
18: m.p.: 168-170°C 
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IR: ν [cm-1] ~ 2100 azide accumulated double bond valency oscillation, 2876 (w), 
1300 (s) =CH2 valency and deformation oscillation, 1740(s) -C=O valency oscillation 
1372 (O)COCH3 valency oscillation. 
 
 
1H-NMR (CDCl3, 400 MHz) δ [ppm]: 
 
5.85 (m: 1H; allyl –CH2-CH=CH2); 5.27-5.15 (dd; 2H; allyl-=CH2); 5.15 (dd;1H; H3’; 
J3’,4’=9.50 Hz); 5.12 (dd; 1H; H3; J3,4=9.74 Hz); 5.03 (dd; 1H; H4; J4,5=9.40 Hz); 4.94 
(dd; 1H; H2’; J2’,3’=9.45 Hz); 4.88 (dd; 1H; H2; J2,3=9.45 Hz); 4.53 (d; 1H; H1’; 
J1’,2’=7.93 Hz); 4.50 (d; 1H; H1; J1,2=6.99 Hz); 4.35-4.29 (dd; 2H; allyl-=CH2); 4.28 
(dd; 1H; H6a; J5,6a=4.90 Hz); 4.03 (dd; 1H; H6b; J5,6b=12.43 Hz; J6a,6b=12.43 Hz); 
3.75 (dd; 1H; H4’; J4’,5’=6.83 Hz); 3.65 (m; 1H; H5); 3.54 (dd; 1H; H5’); 3.52 (dd; 1H; 
H6a’; J5’,6a’=6.41 Hz); 3.37 (dd; 1H; H6b’; J5’,6b’=13.18 Hz; J6a’,6b’=13.18 Hz); 2.06 (s; 
3H; -COCH3); 2.01 (s; 3H; -COCH3); 2.00 (s; 3H; -COCH3); 1.99 (s; 3H; COCH3); 
1.98 (s; 3H; -COCH3); 1.95 (s; 3H; -COCH3). 
 
13C-NMR (CDCl3, 100 MHz) δ [ppm]: 
 
171.89, 171.64, 171.20, 170.93, 170.69, 170.23 (6C, -COCH3); 134.72 (allyl –
CH=CH2); 119.06 (allyl -=CH2); 102.01 (C1); 100.74 (C1’), 75.89 (C4’); 74.28 (C5’); 
73.78 (C3); 73.51 (C3’); 73.43 (C5); 73.10 (C2); 72.90 (C2’); 71.22 (allyl –O-CH2-); 
69.26 (C4); 62.96 (C6); 51.67 (C6’); 22.07-21.93 (s; 6C; -COCH3). 
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2’,3’,4’,6’-Tetra-O-acetyl-β-D-glucopyranosyl-(1→4)-2,3-di-O-acetyl-6-azido-6-
deoxy-β-D-glucopyranose  19 
 
 
 
 
 
Preparation: 69 
 
In a round bottom flask, 1.10 g (1.66 mmole) of compound 18, was dissolved in 60 ml 
of 88% acetic acid. To this solution, 1.20 g of sodium acetate 1.20 g of PdCl2 were 
added. The reaction mixture was stirred for 48 hours, after that TLC showed the 
complete consumption of 18.  The reaction mixture was neutralized with saturated 
solution of NaHCO3, 50 ml chloroform was added and the mixture filtered over a pad 
of Celite®. The chloroform phase was separated in a separatory funnel, dried over 
anhydrous MgSO4, filtered and evaporated under vacuum to afford 992 mg (1.60 
mmole) of 19 with yield of 96%. Column chromatography (EE: T/ 3:2) afforded 794 
mg (1.28 mmole) pure crystals of 19 (80% total yield). 
 
 
Characterization: 
 
TLC (EE: T / 3:2):    RF educt 18 0.65 
      product 19 0.24 
 
19: Optical rotation: [ ]20Dα = + 40.15° (CHCl3; 0.050 g/100 ml) 
 
19: m.p.: 151°-152°C 
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IR: ν [cm-1] ~3600 –OH valency oscillation, ~ 2100 azide accumulated double bond 
valency oscillation, 2876 (w), 1300 (s) =CH2 valency and deformation oscillation, 
1740(s) -C=O valency oscillation, 1372 (O)COCH3 valency oscillation. 
 
1H-NMR (CDCl3, 400 MHz) δ [ppm]: 
 
4.80-5.20 (m; 4H; H1, H2; H3, H3’); 4.53 (dd; 1H; H2’; J2’,3’ =8 Hz); 4.50 (dd; 1H; H4’; 
J4’,5’ =7.99 Hz); 4.32 (dd; 1H; H6a’; J5’,6a’ =4.34 Hz; J6a’,6b’ =12.33 Hz); 4.16 (d; 1H; H1’; 
J1’,2’ =7.76 Hz); 4.05 (dd; 1H; H6b’; J5’,6b’ =8.22 Hz); 3.80 (dd; 1H; H4; J3,4=9.14 Hz); 
3.65 (m; 1H; H5; J4,5=9.60 Hz); 3.56 (dd; 1H; H5’); 3.52 (dd; 1H; H6a); 3.35 (dd; 1H; 
H6b; J5,6b=5.03 Hz; J6a,6b=13.94 Hz); 2.19-1.90 (6 s; 18H; -COCH3). 
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β-D-Glucopyranosyl-(1→4)-6-azido-6-deoxy-β-D-glucopyranose 20 A 
 
 
 
 
 
Preparation: 
 
Compound 19 (300 mg 0.49 mmole) was suspended in 10 ml of dry methanol, and  
a catalytic  amount (0.2 ml) of freshly prepared sodium methoxide (230 mg Na /100ml 
methanol) was added to the reaction mixture. After TLC had indicated the complete 
conversion of 19 to 20 A, the reaction mixture was neutralized by Dowex®-H+ , 
filtered and evaporated under vacuum to give 177 mg (0.48 mmole) of 20 A. 
 
 
Characterization: 
 
TLC (EE: T / 3:2): RF educt 19 0.25 
    product 20 A 0.05 
20 A: m.p.: 155°-158°C 
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2’,3’,4’,6’-Tetra-O-acetyl-β-D-glucopyranosyl-(1→4)-1,2,3-tri-O-acetyl-6-azido-
6-deoxy-β-D-glucopyranose 20 B 
 
 
 
 
Preparation: 
 
Compound 19 (300 mg, 0.49 mmole) was dissolved in 5.0 ml of dry pyridine. The 
solution was cooled in an ice-water bath. To the magnetically stirred solution, acetic 
anhydride ( 5.0 ml) was dropped from a dropping funnel sealed with a drying tube 
and the mixture stirred further over night. After TLC had indicated the end of the 
reaction the reaction mixture was poured onto ice , stirred for 30 min. filtered under 
vacuum and washed several times with destilled water. The product was dried in a 
desiccator to give 324 mg of product 20 B (100% yield). 
 
Characterisation: 
 
TLC (EE:T / 3:2):   RF educt 19 0.25 
     product 20 B 0.69 
 
20 B: Optical rotation: [ ]20Dα = + 49.18° (CHCl3; 0.02 g/100 ml) 
 
20B: m.p.: 184-188°C 
 
IR: ν [cm-1] 2105 azide accumulated double bond valency oscillation, 1370 
(O)COCH3 valency oscillation, 1740(s) -C=O valency oscillation. 
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1H-NMR (CDCl3, 400 MHz) δ [ppm]: 
 
5.64 (d; 1H; H1; J1,2=8.22 Hz); 5.19 (dd; 1H; H3; J3,4=13.79 Hz); 5.15 (dd; 1H; H3’; 
J3’,4’ =9.14 Hz); 5.05 (dd; 1H; H2’); 5.01 (dd; 1H; H4’; J4’,5’ =9.37 Hz); 4.87 (dd; 1H; 
H2; J2,3=9.14 Hz); 4.54 (d; 1H; H1’; J1’,2’ =7.99 Hz); 4.35 (dd; 1H; H6a’; J5’,6a’ =2.05 
Hz); 4.03 (dd; 1H; H6b’; J5,6b’ =10.38 Hz; J6a’,6b’ =12.11 Hz); 3.87 (dd; 1H; H4; 
J4,5=9.59 Hz); 3.70-3.60 (m; 3H; H5, H5’, H6a); 3.36 (dd; 1H; H6b; J5,6b=10.05 Hz; 
J6a,6b =13,47 Hz; J5,6a=3.66 Hz); 2.10-1.94 (7 s; 21H; -COCH3). 
 
13C-NMR (CDCl3, 100 MHz) δ [ppm]: 
 
170.47, 170.22, 169.63, 169.40, 169.26, 168.95, 168.78 (7C, -COCH3); 100.39 (C1’); 
91.70 (C1), 75.48 (C4); 74.68 (C5’); 72.86 (C5’); 72.33 (C3’); 72.02 (C3); 71.62 (C2’); 
70.34 (C4’); 61.54 (C2’); 61.45 (C6’); 49.65 (C6); 20.75, 20.63, 20,58, 20.55, 20.52, 
20.51, 20.47 (7 s; 7C; -COCH3). 
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1,2,3,4,6-Penta-O-acetyl-β-D-glucopyranose 22 
 
 
 
 
 
Preparation : 
 
In a 500 ml round bottom flask, (50g, 0.277 mole) of glucose 21 was suspended in 
(150 ml) dry pyridine and150 ml (1.575 mole) acetic anhydride was dropped into the 
suspension from a dropping funnel sealed with a drying tube (Drierite). The reaction 
mixture was cooled in an ice-water bath, stirred with a magnetic stirrer and allowed to 
come to room temperature. After stirring over night, the content of the flask was 
poured onto ice and stirred for a further for 30 min. The formed product was filtered 
under vacuum and washed several times with distilled water. The product was stored 
in. a desiccator over Drierite and gave a total yield 108.0 g (0.277mole) of 22 
(100%). 
 
Characterisation: 
 
TLC (EE:T 3:2): RF  educt 21 0.01 
    product 22 0.70 
 
22: Optical rotation: [ ]20Dα  = + 30.5°  (CHCl3; 0.41 g/100 ml)
 
22: m.p.: 87-89°C 
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2,3,4,6-Tetra-O-acetyl-1-bromo-1-deoxy-α-D-glucopyranoside 23 
 
 
 
 
 
Preparation: 
 
100 g of glucose pentaacetate 22 (0.256mole) was dissolved in 200 ml dry 
chloroform and magnetically stirred in an ice-water bath. 120 ml of hydrogen bromide 
in acetic acid (30 wt %) diluted with 20 ml dry chloroform was dropped in over 30min 
from a dropping funnel sealed with a drying tube (Drierite). The reaction mixture 
was stirred for another 4h. After TLC indicated the complete consumption of the 
starting material, the reaction mixture was poured in a separatory funnel onto ice-
water and extracted with chloroform. The chloroform layer washed 4 times with ice-
cold water, once with NaHCO3 and finally with NaHSO4. The chloroform layer was 
then dried over anhydrous Mg2SO4, filtered and evaporated under vacuum to give 
101.0 g (0.246 mole) white crystals of product 23. The product was recrystallized 
from diisopropylether  to give 92.0 g (0.224 mole) of the pure product with total yield 
of 87%. After recrystallization the product was stable over several months.  
 
Characterisation: 
 
TLC (EE:T 3:2):   RF  educt 22 0.59 
      product 23 0.70 
 
23: Optical rotation:  [ ]20Dα
 
 = + 194° (CHCl3; 4.00 g/100 ml)
 
23:m.p.: 89-91°C 
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Allyl-2,3,4,6-tetra-O-acetyl-β-D-glucopyranoside 24 
 
 
O
AcO
AcO
AcO
OAc
Br
O
AcO
AcO
O
AcO
OAc
Hg(CN)2 / AllOH C17H24O10
Mol. Wt.: 388,37
C, 52.57; H, 6.23; O, 41.20CH2Cl2
23 24
 
 
 
Preparation : 
 
In a 250 ml round bottom flask, tetra-O-acetyl glucosyl bromide (25.0 g 0.061 mole) 
23 was dissolved in 60 ml dry CH2Cl2, 9.0 g of preheated molecular sieves was 
added. To the magnetically stirred solution 5 g of mercury (II) cyanide and 7.0 ml of 
dry allyl alcohol were added and the flask was sealed with a drying tube (Drierite). 
After 36 hours stirring at room temperature, thin layer chromatography (EE: T / 3:2) 
indicated the complete consumption of 23. The reaction mixture was then diluted with 
50 ml of CH2Cl2 stirred for a further 30 min., the reaction mixture was then filtered 
over a pad of Celite®, and the filtrate was evaporated under vacuum to give 26.0 g of 
24. After recrystallization from isopropanol the total yield of compound 24 was 19.0 g 
(0.049 mole, 80 %).     
 
Characterisation: 
 
TLC (EE:T/ 3:2):    RF educt 23 0.75  
product 24 0.70 
 
24: Optical rotation: [ ]20Dα  = -1.7° (CHCl3; 0.03 g/100 ml) 
24: m.p.: 87-88°C 
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Allyl- β-D-glucopyranoside 25 
 
 
 
 
 
Preparation: 
 
In a 100 ml round bottom flask 4.18 g (0.011 mole) of 24 was dissolved in 25 ml dry 
methanol. To the magnetically stirred solution 6.0 ml of freshly prepared CH3ONa 
(300 mg Na / 100ml CH3OH) was added. After 2 h at room temperature TLC (EE:T / 
3:2) indicated the complete consumption of the educt. The solution was neutralized 
with Dowex® 50-H+, filtered and evaporated to give 2.5 g (0.113 mole ~100%) of 25. 
 
 
Characterisation: 
 
TLC (EE:T / 3:2): RF   educt 24 0.64 
      product 25 0.00 
 
TLC (Propanol:water / 17:3)  educt 24 0.85 
      Product 25 0.50 
 
25 Optical rotation [ ]20Dα  = - 33° (H2O; 5.00 g/100 ml) 
25: m.p.: 100-102°C 
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Allyl-6-O-methylsulfonyl-β-D-glucopyranoside 26 
 
 
 
 
 
Preparation: 
 
In a 100 ml round bottom flask 4.40 g (0.021 mole) of compound 25 was dissolved in 
20 ml dry pyridine. To the magnetically stirred solution 2.48 ml (0.687 mmole) of 
methanesulfonyl chloride diluted with 10 ml of dry CH2Cl2 was dropped through a 
dropping funnel over 4h. The reaction temperature was kept constant at -30°C using 
dry ice. After TLC had indicated the complete consumption of the starting material, 
the reaction mixture was poured onto ice, stirred for a further 30 min. then extracted 
with chloroform. The chloroform phase was washed once with NaHSO4 then with 
NaHCO3, dried over anhydrous Mg2SO4, filtered and finally evaporated under 
vacuum to give 4.76 g (0.016 mole) of a syrupy product of 26 with a yield of 76%. 
Compound 26 was directly applied for the next step without any further purification. 
 
 
Characterisation: 
 
TLC (EE:Iso  / 10:1):   RF educt 25 0.10 
      product 26 0.41 
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Allyl-2,3,4-tri-O-acetyl-6-O-methylsulfonyl-β-D-glucopyranoside 27 
 
 
 
 
 
Preparation: 
 
To the sirupy product 26 (4.76 g 0.016 mole), 20 ml of dry pyridine and 20 ml of 
acetic anhydride were added. The reaction mixture was stirred in an ice-water bath 
over night. After TLC had indicated the complete consumption of the educt, the 
reaction mixture was poured onto ice, stirred , filtered under vacuum and washed 
several times with distilled water. The product was then recrystallized from 50% 
ethanol to give 6.70 g (0.016 mole) of  pure crystals of 27 with a yield of 100%. 
 
 
Characterisation: 
 
TLC (EE: T / 3:2): RF educt  26 0.31 
    product 27 0.73 
 
27: Optical rotation [ ]20Dα  = - 2.8° (CHCl3; 0.021g /100 ml) 
27: m.p.: 115°- 117°C 
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Allyl-2,3,4-tri-O-acetyl-6-azido-6-deoxy-β-D-glucopyranoside 28 
 
 
 
 
Preparation: 
  
In a round bottom flask, 6.70 g (0.016 mole) of 27 was dissolved in 50 ml dried DMF. 
To this solution 5.80 g NaN3 was added and refluxed in an oil bath at 120°C for 2h. 
After TLC had indicated the end of the reaction, the reaction mixture was cooled and 
evaporated under vacuum. The residue was partitioned between chloroform and 
water, the chloroform phase separated in a separatory funnel and washed several 
times with water. The organic layer was then dried over anhydrous Mg2SO4, filtered 
and evaporated under vacuum to afford 5.0 g (0.014 mole) of 28 with a yield of 84%. 
 
 
Characterization: 
 
TLC (EE: T / 3:2):   RF educt 27 0.70 
     product 28 0.82 
28: Optical rotation [ ]20Dα  = - 13.2° (CHCl3; 0.028 g/100 ml) 
28: m.p.: 119°- 121°C 
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2,3,4-Tri-O-acetyl-6-azido-6-deoxy-β-D-glucopyranose 29 
 
 
 
 
Preparation: 
 
In a round bottom flask, 5.0 g (0.013 mole) of compound 28 was dissolved in 100 ml 
of 88% acetic acid. To this solution, 3.5 g of sodium acetate and 1.75 g of PdCl2 were 
added. The reaction mixture was stirred for 48 h after that, TLC showed the complete 
consumption of 28.  The reaction mixture was neutralized with saturated solution of 
NaHCO3, 100 ml chloroform was added and the mixture filtered over a pad of Celite®. 
The chloroform phase was separated in a separatory funnel, dried over anhydrous 
MgSO4, filtered and evaporated under vacuum to afford 4.2 g (0.0126 mole) of 29  
(yield, 97%). Column chromatography (EE:T/ 3:2) afforded 3.5 g (0.011 mole) of 
syrupy 29  (81% yield). 
 
Characterization: 
 
TLC (EE: T / 3:2):   RF educt 28 0.73 
     product 29 0.32 
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6-Azido-6-deoxy-D-glucose 30 
 
 
 
 
 
Preparation: 
 
In a 100 ml round bottom flask, 1.5 g (4.5 mmole) of compound 29 was suspended in 
25 ml dry methanol, and a catalytic amount (0.2 ml) of freshly prepared sodium 
methoxide (230 mg Na / 100 ml methanol) was added to the reaction mixture. After 
TLC indicated the complete conversion of 29 to 30, the reaction mixture was 
neutralized with Dowex®-H+, filtered and evaporated under vacuum to afford 885 mg 
(4.31 mmole) of 30 (95%). 
 
Characterization: 
 
TLC (EE: T / 3:2): RF  educt 29 0.25 
     product 30 0.00 
TLC ( propanol:water/ 17:3) educt 29 0.80 
     Product30 0.63 
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1,2:5,6-Di-O-isopropylidene-α-D-glucofuranose 31 
 
 
1,2:5,6-Di-O-isopropylidene-α-D-glucofuranose 31 was purchased from GLYCON 
Bioch. GmbH, Biotechnology, Luckenwalde, Germany 
 
1H-NMR (CDCl3, 400 MHz) δ [ppm]: 
5.94 (d;1H; H1; J1,2=3.79 Hz); 4.53 (d;1H; H2; J2,3=6.06 Hz); 4.37-4.30 (m; 2H; H5, 
H3; J3,4=3.03 Hz, J4,5=7.83 Hz, J3,-OH=3.79 Hz); 4.20-4.15 (dd; 1H; H6; J5,6=6.06 Hz); 
4.09-4.05 (dd; 1H;H4); 4.00-3.95 (dd; 1H; H6’; J5,6’=7.57 Hz, J6,6’=8.84 Hz); 2.54 (d; 
1H; -OH); 1.49, 1.44, 1.36, 1.31 (4 s; 4x3 H; 4x -CH3). 
 
 
13C-NMR (CDCl3, 100 MHz) δ [ppm]: 
111.81, 109.65 (2 quaternary carbon atoms (CH3)2-C=); 105.29 (C1); 85.07 (C2); 
81.12 (C4); 75.25 (C3); 73.51 (C5); 67.66 (C6); 26.84, 26.75, 26.17,25.12 (4 primary 
carbon atoms -C-CH3 ). 
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1,2:5,6-Di-O-isopropylidene-α-D-ribo-hexofuranose-3-ulose 32 
 
 
 
Preparation70 : 
 
To a mixture of 100 ml of acetic anhydride and 400 ml of dry DMSO heated to 50°C 
in a 1-liter round bottom flask was added 50 g (0.192 mole) of 31. The reaction 
mixture was magnetically stirred and refluxed in an oil bath at 80°C. After TLC had 
indicated the complete consumption of 31 (Both educt and product have the same Rf 
value; in order to monitor the end of the reaction, a sample of the reaction mixture 
was reduced to the allofuranose derivative 33.  complete conversion to 33 indicated 
the complete consumption of 31 ). The solution was concentrated under vacuum and 
afforded 49.0 g (0.190 mole) syrupy product  32 (99 %). For the characterization of 
the product, 1.0 g was recrystallized from diisopropylether to afford fine crystals with 
melting point of 60°-62°C. The rest of the product was applied directly for the next 
step without further treatment. 
 
Characterization:   
TLC (EE:T / 1:1) Rf     educt 0.69 
      Product 0.69 
32 Optical rotation:
 
[ ]20Dα  = + 20.1° (CHCl3; 0.22 g/100 ml) 
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32:m.p. 60-62°C 
1,2:5,6-Di-O-isopropyliden-α-D-allofuranose 33 
 
 
 
 
Preparation: 
 
To the crude syrupy oxidation product 32 (48.0 g) was added 300 ml of 95% ethanol, 
and the solution was cooled in ice-water bath. Sodium borohydride (5.0 g) was added 
to the cold, magnetically stirred solution. After 20 min, the cooling bath was removed 
and stirring continued for 2 h at RT. After TLC had indicated the end of the reduction 
process, the reaction mixture was concentrated to dryness under vacuum, and the 
residue shaken with a mixture of 300 ml of water and 75 ml of chloroform. The 
aqueous layer was extracted with chloroform (3x50 ml), and each chloroform extract 
was washed with 75 ml water. The chloroform extracts were combined and 
evaporated under vacuum to give 44.43 g (0.17 mole) of 33. The product was 
recrystallized from cyclohexane. 
 
Characterization: 
 
TLC (EE:T / 1:1) Rf    educt32 0.61 
     Product33 0.32 
33 Optical rotation  [ ]20Dα  = + 34.18° (CHCl3; 0.43 g/100 ml) 
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33 m.p 69-71°C 
 
1H-NMR (CDCl3, 400 MHz) δ [ppm]: 
5.80 (d; 1H; H1; J1,2=3.79 Hz); 4.61 (dd; 1H; H2; J2,3=5.30 Hz); 4.33-4.28 (m; 1H; H5; 
J5,6=7.57 Hz, 4.10-3.98 (m; 3H; H3, H6, H6’; J3,4=4.55 Hz); 3.83-3.79 (dd; 1H; H4; 
J4,5=8.34 Hz); 4.00-3.95 (dd; 1H; H6’; J5,6’=7.57 Hz); 2.53 (d; 1H; -OH; J3,-OH=8.59 
Hz); 1.57, 1.62, 1.38, 1.36 (4 s; 4x3 H; 4x -CH3). 
 
13C-NMR (CDCl3, 100 MHz) δ [ppm]: 
112.85, 109.86 (2 quaternary carbon atoms (CH3)2-C=); 103.94 (C1); 79.76 (C4); 
78.96 (C2); 75.61 (C5); 72.52 (C3); 65.89 (C6); 26.56, 26.50, 26.31, 25.27 (4 primary 
carbon atoms-C-CH3). 
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1,2:5,6-Di-O-isopropyliden-3-O-methylsulfonyl-α-D-allofuranose 34 
 
 
 
 
Preparation: 
 
In a 250 round bottom flask 5.0 g (0.019 mole) of compound 33 was dissolved in 20 
ml of dry pyridine and cooled in ice-water bath. To the magnetically stirred solution, 
1,6 ml (0.021 mole) of methyl sulfonyl chloride diluted to 10 ml with dry CH2Cl2 was 
dropped through a dropping funnel over 30 min. After TLC had indicated the 
consumption of 33 , the reaction mixture was poured onto ice and stirred for a further 
30 min. In a separatory funnel 34 was partitioned between CHCl3 and water. The 
chloroform phase was washed with saturated solution of NaHSO4, then NaHCO3, 
dried over anhydrous MgSO4, filtered and finally evaporated under vacuum to afford 
5.80 g (0.017 mole) of 34 (90%). The product was recrystallized from 50% ethanol.  
 
Characterization: 
 
TLC (EE:T / 3:2)  Rf   educt 33 0.32 
     Product 34 0.69 
34 Optical rotation [ ]20Dα  = + 86.0° (CHCl3; 0.1 g/100 ml) 
34 m.p.: 128-130°C 
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1H-NMR (CDCl3, 400 MHz) δ [ppm]: 
5.82 (d; 1H; H1; J1,2=3.79 Hz); 4.82-4.77 (m; 2H; H2, H3; J2,3=4.80 Hz); 4.34-4.30 
(m;1H; H5; J4,5=7.83 Hz, J5,6=7.84 Hz); 4.15-4.07 (m; 2H; H4, H6; J3,4=4.29 Hz); 
3.95-3.91(dd; 1H; H6’; J5,6’=8.85 Hz, J6,6’=5.81 Hz);3.14 (s; 3H; -SO2CH3); 1.58, 
1.48, 1.37, 1.36 (4s; 4x3 H; 4x -CH3). 
13C-NMR (CDCl3, 100 MHz) δ [ppm]: 
117.05, 113.76 (2 quaternary carbon atoms (CH3)2-C=); 103.95 (C1); 77.99 (C3); 
77.15 (C2); 77.01 (C4); 74.79 (C5); 65.61 (C6); 38.86 (1 primary carbon atom of the 
mesyl group –SO2-CH3) ; 26.71, 26.66, 26.24, 24.96 (4 primary carbon atoms -C-
CH3). 
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1,2:5,6-Di-O-isopropyliden-3-azido-3-deoxy-α-D-glucofuranose 35 
 
 
O
O
O
O
O
MsO
34
NaN3 / DMF
O
O
O
O
O
N3
35
170°C
C12H19N3O5
Mol. Wt.: 285,30
C, 50.52; H, 6.71; N, 14.73; O, 28.04
 
  
Preparation: 
 
In a 100 ml round bottom flask 3.34 g (9.8 mmole) of compound 34 and 10.7 g NaN3 
were added to 100 ml dry DMF, the flask was sealed with a drying tube, stirred and 
heated in an oil bath at 170°C (condenser). When TLC (EE: T / 3:2) had indicated the 
complete consumption of the educt, the heater was turned off and the solution was 
cooled to RT. The reaction mixture was evaporated under vacuum to dryness, the 
residue was partitioned between 100 ml water and 100 ml chloroform, the chloroform 
phase washed 5 times with water, then dried over MgSO4 , filtered and finally 
evaporated to give 2.46 g (8.6 mmole) of 35 which was purified by column 
chromatography (EE:T 3:2). 
 
Characterization: 
 
TLC (EE:T / 3:2)  Rf   educt 34 0.69 
     Product 35 0.82 
35 Optical rotation [ ]20Dα  = − 39.85.0° (CHCl3; 4.8 g/100 ml) 
35 m.p.: 132°- 134°C 
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1H-NMR (CDCl3, 400 MHz) δ [ppm]: 
 
5.85 (d; 1H; H1; J1,2=3.54 Hz); 4.61 (d; 1H; H2, J2,3=5.05 Hz); 4.25-4.21 (m; 1H; 
H5;J4,5=6.06 Hz); 4.15-4.07 (m; 3H; H3, H4, H6; J3,4=3.54 Hz, J5,6=8.85 Hz); 3.99-
3.96 (dd; 
1H; H6’; J5,6’=4.04 Hz, J6,6’=4.80 Hz); 1.50, 1.43, 1.36, 1.32 (4 s; 4x3 H; 4x -CH3). 
 
13C-NMR (CDCl3, 100 MHz) δ [ppm]: 
 
112.32, 109.58 (2 quaternary carbon atoms (CH3)2-C=); 105.05 (C1); 83.43 (C2); 
80.15 (C4); 73.05 (C5); 67.65 (C6); 66.38 (C3); 26.86, 26.65, 26.19, 25.15 (4 primary 
carbon atoms -C-CH3). 
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3-Azido-3-deoxy-β-D-glucose 36 
 
 
 
 
Preparation: 
In a 250 ml round bottom flask, 2.0 g (7.0 mmole) of compound 35 was suspended in 
50 ml H2O. Dowex®-H+ (3.0 g) was added to this mixture and refluxed at 45°C. After 
TLC (EE:T / 3:2) had indicated the consumption of the starting material, the reaction 
mixture was cooled, filtered and evaporated under vacuum at 40°C to afford 1.45 g 
(7.0 mmole)  syrupy product of 36. 
 
Characterization: 
 
TLC(EE:T / 3:2)   educt 35 0.82 
     Product 36 0.01 
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β-D-Allose 37 
 
 
 
Preparation: 
 
In a 250 ml round bottom flask 10.20 g (0.039 mole) of compound 33 was suspended 
in 100 ml H2O. Dowex®-H+ (17.0 g) was added to this mixture and refluxed at 45°C. 
After TLC (EE:T / 3:2) has indicated the consumption of the starting materials, the 
reaction mixture cooled, filtered and the evaporated under vacuum at 40°C to afford 
6.86 g (0.038 mole) of a white crystalline product of 37. The β-D-allose was 
recrystallized from 20 ml of 30% ethanol to give needle crystals with m.p. 141°-
142°C. 
 
Characterization: 
 
TLC(EE:T / 3:2)   educt33 0.73 
     Product37 0.0 
TLC(Pr: H2O / 17:3:)  educt33 0.85 
     Product37 0.68 
37 optical rotation.
 
[ ]20Dα  = + 14.5° (H2O; 2.0 g/100 ml) 
37 m.p.: 141°-142°C 
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7.5 Enzymatic syntheses description 
 
7.5.1 Glucose oxidase catalysis 
6-Azido-6-deoxy-D-glucono-1,5-lactone 
 
 
 
 
Incubation: 
 
An aqueous solution of compound 30 was prepared (0.5 g in 10 ml H2O) in a test 
tube. To this solution 30 mg of glucose oxidase(105 U) and 3.60 mg of catalase 
enzyme ( 6.7 U) were added. The pH of the solution was adjusted at 7.0 and the 
reaction mixture was incubated at RT. Using TLC in propanol/water 17:3 as a mobile 
phase we could not identify any changes in the substrate. 
 
Conclusion: 
The substitution of hydroxyl group on C6 of glucose with azido group render the 
molecule incapable of functioning as substrate of glucose oxidase. A conventional 
chemical oxidation process may be used instead of enzymatic one, for example the 
oxidation with bromine water or with DMSO. 
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7.5.2 Cellobiose dehydrogenase catalysis 
 
6’-Azido-6’-deoxy-β-D-glucopyranosyl-(1→4)-D-gluconic acid delta lactone 38 
 
 
 
 
 
β-D-Glucopyranosyl-(1→4)-6-azido-6-deoxy-D-gluconic acid delta lactone 39 
 
 
 
 
 
β-D-Glucopyranosyl-(1→4)-D-gluconic acid delta lactone 40 
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Incubation: 
 
In 3 test tubes, the substrates 13, 20, 
 and 1 were incubated with the enzyme 
 cellobiose dehydrogenase in the  
presence of 0.1M potassium  
hexacyanoferrateshown in Table 3.  
The incubation was carried out at 30°C  
and pH 4.0 using acetate buffer.  
Samples were withdrawn in one h intervals ,  
and analyzed by TLC using propanol/water 17:3 as a mobile phase. 
 
Results: 
As shown in Figure 33 the spots 1 in red,  
 2 in blue and 3 in green represent the  
formed lactones from cellobiose, 6-azido-6- 
deoxy-D-cellobiose and 6’-azido-6’-deoxy- 
D-cellobiose respectively. The formation of 
the product 39 was already completed 
 after 2 hours, whereas the formation of compounds 38 and 40 needed 24 hours.  
 
Conclusion: 
The finding that cellobiose dehydrogenase can oxidize cellobiose analogs with azido 
group in the six position of both reduced and non-reduced glucose moiety enables 
the introduction of new precursors for the formation of new biomimetic materials. 
 
 
Entry 
 
Substrate 
 
mg 
Enzyme 
CDH 
in µl 
Catalyst 
 
K3[Fe(CN)6] 
1 
6‘-azido-
6‘-deoxy-
cellobiose 
120 660 1.0 ml 
2 
6-azido-6-
deoxy-
cellobiose 
20 110 1.0 ml 
3 
 
Cellobiose 
 
 
5 30 1.0 ml 
Table 3 
 
Figure 33 
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7.5.3 Cellobiose phosphorylase catalysis 
 7.5.3.1 Phosphorylation of Disaccharides 
  7.5.3.1.1 Phosphorylation of 6-azido-6-deoxy-D-cellobiose 
and formation of 
6-Azido-6-deoxy-D-glucose 30 
 
 
 
Incubation: 
 
Compound 20 was incubated with the enzyme  
cellobiose phosphorylase at 37°C for 12 hours 
 according to Table 4. The products formed were  
separated using DEAE- cellulose chromatography. 
 
Results:  
As shown in Figure 34 the phosphorylation of  
compound 20 leads to a complete conversion 
 to 6-azido-6-deoxy-D-glucose and glucose  
1-phosphate (lanes 5-7). After chromatographic 
 separation with DEAE-cellulose this compound 
 was identical with the chemically prepared  
compound 30. In lane 4 it is obvious that more 
 
Substance Concentration 
6-Azido-6-
deoxy-D-
cellobiose 
1.2 ml 
0.1 M 
Phosphate 
buffer pH 7.0 0.8 ml 
Cellobiose 
phosphorylase 2.0 ml 
 Table 4 
 
Figure 34 
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polar products, possibly higher oligosaccharides,are also formed and probably 
degraded again later. 
 
Conclusion:  
 
The substitution of hydroxyl group by azido group in the 6-position of cellobiose was 
tolerated by cellobiose phosphorylase. Interestingly, cellobiose phosphorylase seems 
to be able to use 6-azido-6-deoxy-D-cellobiose as acceptor to form higher 
oligosaccharides. 
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7.5.3.1.2 Phosphorylation of 6’-azido-6’-deoxy-cellobiose 
 
 
 
Incubation: 
Compound 13 was incubated with the enzyme 
cellobiose phosphorylase at 37°C for 12 hours 
 according to Table 5. In the first 2 hours samples 
 were withdrawn for TLC in 15 min. intervals, after 
that in 2 h intervals. 
 
Results: 
TLC did not indicate any changes in the educt, or the formation of any product. 
Conclusion: 
The 6´-azido-6´-deoxy-cellobiose was expected to be more readily cleaved under 
catalysis with cellobiose phosphorylase to yield 6-azido-6-deoxy-glucose-1-
phosphate and glucose. In our hands such cleavage did not take place indicating that 
the substitution of the hydroxyl group by azido group at C-6 of the non-reducing 
glucose unit of cellobiose is not tolerated by the enzyme cellobiose phosphorylase. 
 
 
 
 
 
 
Substance Concentration 
6‘-Azido-6‘-
deoxy-D-
cellobiose 
1.2 ml 
0.1 M 
Phosphate 
buffer pH 7.0 0.8 ml 
Cellobiose 
phosphorylase 2.0 ml 
Table 5 
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7.5.3.2 Catalysis of disaccharide formation  
 7.5.3.2.1 Synthesis of 6-azido-6-deoxy-cellobiose 
 
 
 
 
Incubation: 
6-Azido-6-deoxy-D-glucose 30 was incubated 
as acceptor with glucose-1-phosphate as donor 
under catalysis by cellobiose phosphorylase 
 according to Table 6. In this reverse reaction 
 Tris buffer was used instead of phosphate at  
pH 7.0 and 37°C. Samples were withdrawn in 2 h 
 intervals and were examined on TLC in  
1-propanol: water 17:3 as mobile phase.  
 
Results: 
 
As shown in Figure 35 the acceptor 6-azido-6-deoxy 
-D-glucose was able to react with glucose-1-P to  
give the heterodisaccharide 20 . Analysis of this 
product showed it to be identical with the sample  
prepared chemically. 
 
Substance Concentration 
Glucose-6-N3 0.8 ml 0.1 M 
Glucose-1-P 1.2 ml 0.076 M 
Cellobiose 
phosphorylase 2.0 ml 
Tris buffer 4.0 ml 
Table 6 
 
Figure 35 
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Conclusion: 
The ability of 6-azido-6-deoxy-D-glucose to act as a substrate in the reverse action of 
cellobiose phosphorylase is of great importance because it offers a new way to 
synthesize heterodisaccharides with β(1→4) glycosidic bond. The organic chemical 
synthesis of such molecules is well known to be difficult. 
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7.5.3.2.2 Synthesis of 3-azido-3-deoxy-D-cellobiose 
 
 
Incubation: 
 
3-Azido-3-deoxy-D-glucose 36 was incubated  
as glucose acceptor under catalysis by cellobiose  
phosphorylase with glucose-1-P as  a donor. The  
pH of the solution was adjusted at 7.0 using Tris 
buffer as shown in Table 7. The incubation  
continued for 24 h. Samples were  withdrawn in 
2 h intervals and were examined on TLC in 1-propanol: water 17:3 as mobile phase. 
 
Results: 
The TLC did not indicate any changes in the educt or the formation of a product. 
Conclusion:  
3-Azido-3-deoxy-D-glucose can not act as a substrate for the reversal action of 
cellobiose phosphorylase. The location of the azido group at C-3 of glucose  
may inhibit the formation of β(1→4) glycosidic bond 
as a result of the steric hindrance between C-3  
and C-4. 
 
 
Table 7 
Substance Concentration 
Glucose-3-N3 0.8 ml 0.1 M 
Glucose-1-P 1.2 ml 0.076 M 
Cellobiose 
phosphorylase 2.0 ml 
Tris buffer 4.0 ml 
 
Table 7 
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7.5.3.2.3 Synthesis of β-D-glucopyranosyl-(1→4)-β-D-allopyranose 
 
 
Incubation: 
 
β-D-Allose 37 was incubated as a glucose acceptor  
with glucose-1-P as a donor under  catalysis by  
cellobiose phosphorylase. Using Tris buffer the pH   
 of the solution was adjusted at 7.0 as shown in  
Table 8. The incubation continued for 24 hours 
and samples were withdrawn in 2 hours intervals  
during the first 6 hours, then every 6 hours. 
 Samples were examined on TLC in 1-propanol: water 17:3 as mobile phase. 
 
Results: 
The TLC did not indicate any change in the educt or the formation of a product. 
Conclusion:  
The change of only one stereocentre on β-D-allose namely position 3 hinder the 
formation of heterodisacchride. Consequently, the β-D-allose cannot act as a 
substrate for the reversal action of cellobiose phosphorylase.  
That means either the equatorial configuration of the hydroxyl  
on C-3 is essential for the substrate-enzyme binding, or that 
 the axial orientation of the hydroxyl group inhibits the binding. 
Table 8 
Substance Concentration 
β-D-Allose 0.8 ml 0.1 M 
Glucose-1-P 1.2 ml 0.076 M 
Cellobiose 
phosphorylase 2.0 ml 
Tris buffer 4.0 ml 
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